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Summary 
 
Proteins have evolved through selective pressure to accomplish specific functions. 
The functional properties of proteins depend upon their three-dimensional structures, 
which result from amino acid sequences folding into tightly packed domains. Methods 
and algorithms to predict and decipher how amino acid sequences shape three-
dimensional structures are essential to understand and modulate protein function 
rationally. Protein design aims precisely at providing tools to achieve this goal. 
The predictive power of rational design methods has dramatically increased over the 
past five years. A broad range of studies now illustrate how the sequence of proteins and 
peptides can be tuned to engineer biological tools with intended properties [1-2]. The 
extensive characterization of peptides and protein mutants has enormously benefited the 
understanding of protein sequence-to-structure relationships. Synergies between 
computational and experimental approaches have also added momentum to the advancing 
limits of design methods. The potential applications in fundamental biochemistry and in 
biotechnology justify the considerable excitement that this progress has generated within 
the research community. The field is probably mature enough so that expert knowledge 
can assist researchers of diverse disciplines to rationally create with maximum 
confidence in a successful return. 
The basic concepts underlying rational design of proteins are intimately related to 
their three-dimensional structures. The stability of a given structure results from a 
complex combination of interactions that favour a specified conformation at the expense 
of any alternative one. Researchers have devised different strategies to extract the general 
principles on which protein structure is based. Proteins have been systematically mutated 
to address the question of how specific residues affect the stability of a given protein [3-
4]. Proteins have been also “redesigned”, starting with a protein of known structure and 
dramatically modifying features of its construction [5]. For the sake of simplicity, initial 
works in the field of design were dedicated to the elucidation of the factors contributing 
to the stability of elementary building blocks.  
Peptide model systems have been shown to be very suitable to this end. They have 
served to dissect the relative energetic contributions of short- and long-range interactions 
to a given folding motif. They have provided key insights into the relationship between 
  
 
 x 
sequence, folded structure, and stability [6], to be applied in designing artificial 
functional systems for specific applications.  
To this end, metal–containing proteins are of particular interest, because they are 
responsible for catalysing important biological process, such as photosynthesis, 
respiration, water oxidation, molecular oxygen reduction and nitrogen fixation: the 
current challenge is to obtain models as good as, if not better than, natural enzymes for 
structural and functional studies. 
Metalloprotein mimetics have been developed through the introduction of novel 
metal-binding sites into naturally occurring proteins as well as through de novo protein 
design. In this thesis, the challenge of reproducing metalloprotein active sites was 
approached by using a miniaturization process. The attention was centered on iron-
containing proteins, in particular on heme-proteins, through the artificial systems named 
Mimochromes [7-8], and on di-iron-oxo proteins, through the artificial proteins named 
DFs [9-11]. Both classes of models (Figure 1) demonstrate the importance of considering 
numerous structural issues in protein design, to obtain soluble and stable molecules, and 
to optimize metal-binding sites for function. 
 
 
 
 
 
 
 
 
 
      a)       b) 
Figure 1: de-novo designed models. a) Crystal structure of di-Zn(II)-DF1; b) computer model of Fe(III)-
Mimochrome VI. 
 
Then, structural features of DFs and natural di-iron proteins, as well as functional 
elements of Mimochromes and natural HRP were borrowed to obtain a de novo protein 
class with five-coordinated heme-complex and peroxidase activity, named MPs (Figure 
2).  
  
 
 xi 
The basic structure of these models consists in a deuterohemin covalently linked to 
two helix-loop-helix peptide chains. The active site presents:  
(i) an homo-Cys/His residue in a single chain that acts as axial ligand to the iron ion, 
leaving the sixth coordination site able to accommodate exogenous ligands or 
substrates;  
(ii) an Arg residue in the distal site that should be able to activate hydrogen peroxide to 
give HRP-like catalytic process.  
 
 
 
Figure 2: computer model of a new class of heme-binding four-helix buldle structure, MPs. This 
representation highlights the His coordinating residue on the proximal site and the Arg catalytic residue on 
the distal site. 
 
In summary, this thesis reports the last achievements in protein design of di-iron-oxo-
proteins with desired catalytic activity; it also reports design, synthesis and 
characterization of a new class of peptide-based heme-models, named MPs (Mini-
Peroxidases), as well as preliminary catalytic activity studies. 
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1.1 Metal ions and metalloproteins 
Metals are commonly found as natural constituents of proteins. Nature has learned to 
use the special properties of metal ions to perform a wide variety of specific functions 
associated with life processes, including respiration, much of metabolism, nitrogen 
fixation, photosynthesis, development, nerve transmission, muscle contraction, signal 
transduction, and protection against toxic agents. Unnatural metals have been introduced 
into human biology as diagnostic probes and drugs. 
Metalloprotein is a generic term for a protein that contains a metal ion cofactor [12], 
and metalloproteins that perform a catalytic function are called metalloenzymes. Figure 
3 represents the principal classification of metalloproteins, highlighting their biological 
functions and which metal ions are present.  
A protein-bound metal site consists of one or more metal ions and all protein side 
chains and exogenous bridging and terminal ligands that define the first coordination 
sphere of each metal ion. Such sites, called prosthetic groups, can be classified into five 
basic types with the indicated functions: 
(i) structural - configuration (in part) of protein tertiary and/or quaternary structure; 
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(ii) storage - uptake, binding, and release of metals in soluble form; 
(iii) electron transfer - uptake, release, and storage of electrons; 
(iv) dioxygen binding - metal-O2 coordination and de-coordination; 
(v) catalytic - substrate binding, activation, and turnover. 
METALLOPROTEINS
Transport and storage proteins
PhosphataseZn, Cu, Mg
AminopeptidaseMg, Mn
CarboxypeptidaseZn
Enzyme B12
Coenzyme B12
Co
Superoxide
dismutasesMo, Cu, Zn
Oxidase
Reductase
Hydroxylase
Fe, Mo, Cu
NitrogenaseFe, Mo
Econitase
Endo III
Oxygenase
HydrogenaseFe, Mo
MetallothioneinZn, Hg
HemocyaninCeruloplasminBlue-copperCu
Myoglobin
Hemoglobin
Hemerythrin
Ferritin
Transferrin
Cytochromes
Fe-S proteinFe
Isomerase
synthaseOxidoreductaseHydroxylase
O2 transport 
and storageMetal storage
Electron 
Transfer
Enzymes
 
Figure 3: principal classification of metalloproteins and function of metal ions. 
 
One of the most fascinating topics in bioinorganic chemistry is to understand why the 
same metallic unit can perform very different functions, depending on its chemical 
context in a biological environment. Changes in the number of coordination sites at the 
metal center can be used to control whether electron transfer, substrate activation, or 
ligand binding occurs. Redox potentials can be tuned by the choice of donor atoms from 
amino acid side chains, by distortions of the coordination geometry, as well as by more 
indirect mechanism, such as modulating the hydrophobicity, hydrogen bonding, and local 
dielectric constant of the active site. Control of electron transfer can be achieved by 
substrate binding without coordination through modulation of metal ligation that 
accompanies conformational changes at the active site. Substrate specificity is dictated by 
the positioning of amino acid side chains to construct a pocket for specific delivery of a 
coordinated reactant. Proteins containing more than one prosthetic group can couple 
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multiple processes to accelerate specific reactions or facilitate complex reactions that 
would not otherwise readily occur. Thus, it is clear that without the appropriate metal ion, 
a biochemical reaction catalyzed by a particular metalloenzyme would proceed very 
slowly, if at all.  
The enzyme provides an arrangement of side chain functional groups having an 
appropriate sized hole with the preferred groups on enzyme side chains needed to bind 
the required metal ion. The optimal number of such binding groups is chosen for the 
particular metal ion, together with the appropriate hydrophobic or hydrophilic 
environment in the binding site. Proteins coordinate metal ions with nitrogen, oxygen, 
and sulfur endogenous biological ligands, which are summarized in Table 1.  
Table 1. Endogenous Biological Ligands 
 
   
  
a
 = amino acid residue; side chain C-atom designation: 
  b
 = approximate values in proteins; actual values may vary with protein environment. 
  c
 =  
_NH3+ form ;  d = imidazolium pKa 6-7 ;  e = _HNC(NH2)2+ form. 
  
 
Metal ions may be bound by main chain amino and carbonyl groups, but specific 
binding is achieved by the amino acid side chains, particularly the carboxylate groups of 
aspartic and glutamic acid, the imidazole of histidine, and the phenolate group of 
Chapter 1 - Natural and artificial metalloproteins  
 
 
 - 4 - 
tyrosine. With the exception of tyrosine, each of these amino acids has been observed to 
act as a bridging ligand between two metal ions and to serve as terminal ligand to a single 
ion. Other side chains that bind metal ions include tryptophan (ring nitrogen), cysteine 
(thiol), methionine (thioether), serine and threonine (hydroxyl group), asparagine and 
glutamine (carboxamide group), lysine (amino group) and, perhaps, the guanidine group 
of arginine. 
Many metalloproteins contain organic components in addition to the protein itself. 
These are often referred as prosthetic groups and coenzymes and may contain bound 
metal ions. The term coenzyme refers specifically to enzymes and as such to the 
functional properties of a protein. On the other hand “prosthetic group” emphasizes the 
nature of the binding of a cofactor to a protein (tight or covalent) and thus refers to a 
structural property. Different sources give slightly different definitions of coenzymes and 
prosthetic groups and in 1979 a letter in Trends in Biochemical Sciences [13] defined 
coenzyme as an additional substance apart from protein and substrate that is required for 
enzyme activity, and a prosthetic group as a substance that undergoes its whole catalytic 
cycle attached to a single enzyme molecule. Prosthetic groups include protoporpyrin IX, 
wich is commonly referred as heme as the iron complex. 
Ligands are the atoms or groups of atoms that are bonded to the metal ion, generally 
in an electrostatic manner. They are usually neutral or negatively charged and they 
donate electron density to the metal ion. The coordination number of a metal ion, that is, 
the number of ligand atoms bound to it, is viewed in terms of concentric spheres; the 
inner sphere containing those atoms in contact with the metal ion, the second sphere 
containing those in contact with the inner sphere ligand atoms. The number of atoms in 
these spheres depends on the size of the metal ion and the sizes of the ligand atoms. The 
charge distribution in the active site of an enzyme is designed to stabilize the transition 
state of the catalyzed reaction relative to that of the substrate. In enzyme-catalyzed 
reactions it is essential that the reactants be brought together with the correct spatial 
orientation, otherwise the chance of the reaction taking place is diminished and the 
reaction rate will be too low. The electrostatic environment in the active site is a major 
factor that serves to guide the substrate to the binding site in the correct orientation. 
Metal ions can assist in this process, often binding groups in a stereochemically rigid 
manner, thereby helping to control the action of the enzyme. Thus, an enzyme will bind 
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its substrate in such a manner that immobilization and alignment, ready formation of the 
transition state of the reaction to be catalyzed, and then easy release of the product will 
result; metal ions often help in accomplishing this process. 
Metal ions in biology most frequently bind to donor ligands according to preferences 
dictated by the hard-soft theory of acids and bases. Metal ions are considered to be Lewis 
acids. The word “hard” has been introduced to indicate a low polarizability so that the 
electron cloud is difficult to deform (like a hard sphere). By contrast “soft” means high 
polarizability so that the electron cloud is readily deformed [14]. A hard acid or metal 
cation holds tightly to its electrons and therefore its electron cloud is not readily 
distorted; its unshared valence electrons are not easily excited. Soft (polarizable) metal 
cations contain electrons that are not so tightly held and therefore are easily distorted or 
removed. A hard acid prefers to combine with a hard base, while a soft acid prefers to 
bind with a soft base by partially forming covalent bonds. The type of binding is related 
to the highest occupied molecular orbital (HOMO) of the electron-pair donor (a Lewis 
base, the ligand) and the lowest unoccupied molecular orbital (LUMO) of the electron-
pair acceptor (a Lewis acid, the metal ion). If these orbitals have similar energies, then 
electron transfer will give a covalent (soft-soft) interaction, whereas the energy difference 
is large, electron transfer does not readily take place and the interaction is mainly 
electrostatic (hard-hard). In biological systems, hard ligands generally contain oxygen 
while soft ligands contain sulfur. Hard acids tend to bind hard bases by ionic forces, 
while soft acids bind soft bases by partially forming covalent bonds. These hard-soft 
categorizations help to understand the relative binding preferences of various cations. 
Most metal ions of biological significance are hard or intermediate between hard and 
soft. Most soft metal ions and soft ligands are poisonous and they interact with other soft 
species in the body. Table 2 lists the hard-soft character of essential metal ions and their 
ligands. 
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Table 2. Hard-soft acid-base classification of metal ions and ligands important to bioinorganic 
chemistry 
 
 
 
1.1.1 Iron-proteins 
Iron is the most abundant transition metal in the earth’s crust, and it is perhaps not 
surprising that iron is an important constituent of bioinorganic systems. 
Most well-nourished people in industrialized countries have 3-4 grams of iron in their 
bodies. Of this, about 2.5 g is contained in the hemoglobin needed to carry oxygen 
through the blood. Another 400 mg is devoted to cellular proteins that use iron for 
important cellular processes like storing oxygen (myoglobin), or performing energy-
producing redox reactions (cytochromes); 3-4 mg circulates through the plasma, bound to 
transferrin. Table 3 lists principal iron proteins and their specific functions. 
  
Table 3. Iron proteins and their specific functions* 
PROTEIN M.W. (KDa) Fe (g) in the HUMAN BODY 
Fe 
IONS FUNCTION 
Hemoglobin 64.5 2.6 4 O2 transport 
Myoglobin 17.8 0.3 1 O2 deposit 
Transferrin 76 0.004 2 Fe transport 
Hemosiderin  0.48  Fe deposit 
Catalase 260 0.004 4 H2O2 decomposition 
Perossidasi variable little 1 H2O2 decomposition 
Citocromo-c 12.5 0.004 1 electron transfer 
Cyt P450 50 little 1 Organic substrates hydroxylation 
Fe/S variable 0.004 2-8 electron transfer 
* = data from W.Kaim, B. Scwedersky Bioinorganic Chemistry: Inorganic-Element in the chemistry of Life 
1991, Wiles & Sons. 
 Classification of Lewis Acids       Classification of Bases 
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Iron forms compounds mainly in the +2 and +3 oxidation states. Traditionally, 
iron(II) compounds are called ferrous, and iron(III) compounds ferric. Iron also occurs in 
higher oxidation states: iron(IV) and iron(V) are a common non-isolable intermediates in 
many biochemical oxidation reactions. Iron-proteins present very different redox 
potential values, demonstrating how much influence ligands have on stabilizing metal 
oxidation state. Furthermore, chemical and physical properties of iron complexes are 
kinetically labile and thermodynamically stable at the same time. The lability facilitates 
rapid assembly and disassembly of the metal cores, as well as rapid association and 
dissociation of substrates, while stability ensures conservation of active site structure, 
allowing a specific function possible via energy-driven processes. 
Iron-proteins are very common in nature, in which metal ion is coordinated by 
prosthetic groups, such as porphyrins, or by specific amino acid sequences. This work 
focuses on two classes: the first class, called heme-proteins, can perform a wide variety 
of different functions, ranging from dioxygen transport and storage in hemoglobin and 
myoglobin, electron transfer in cytochrome c, oxygen activation in cytP450, hydrogen 
peroxide destruction in peroxidases, and several kinds of substrate oxidation (Figure 4a) 
[15]; the second class, called di-iron-oxo-proteins, catalyzes a wide range of important 
dioxygen-dependent biological reactions and processes. Examples of the diverse 
functions performed by these enzymes include the selective oxidation of methane to 
methanol by soluble methane monooxygenase, the generation of a catalytically essential 
tyrosyl radical for DNA biosynthesis by ribonucleotide reductase R2 subunit, and the 
desaturation of fatty acids by stearoyl-ACP ∆9-desaturase. Interestingly, despite this 
functional diversity, the active sites of all these di-iron-oxo enzymes are remarkably 
similar, and share two structural motifs: (i) a dioxygen reactive site consisting of two iron 
ions coordinated by two His residues and four carboxylate side chains (Figure 4a) and 
(ii) a four-helix bundle motif that houses the di-iron center (Figure 4b) [16].  
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Figure 4: active site and overall structure of different iron-proteins. a) Cartoon representation of some 
heme-proteins; b) cartoon representation of di-oxo-iron proteins: the four-helix bundle motif is highlighted 
in blue. 
 
Therefore, it seems clear that small differences in the structures of these proteins must 
be responsible for tuning the reactivity of the di-iron site and of the heme group towards 
their different functions.  
Heme-proteins represent one of the most important examples to understand structure–
function relationships, and to design new molecules with desired functions. In this work, 
we analyzed structural and functional properties of natural proteins HRP and cytP450 to 
design a new class of catalytically active enzymes, MPs. 
 
1.1.1.a Horseradish peroxidase  
Horseradish peroxidase is a 44,173.9 dalton glycoprotein that catalyzes the oxidative 
coupling of phenolic compounds using H2O2 as oxidant. The reaction is a three-step 
cyclic reaction in which the enzyme is first oxidized by H2O2 and then reduced in two 
one-electron transfer steps by reducing substrates, tipically a small molecule phenol 
derivative (Figure 5). The oxidized phenolic radicals can polymerize, with the final 
product depending on the chemical character of the radical, the environment and the 
peroxidase isoenzyme used. 
Hemoglobin Mitochondrial cit c Horseradish peroxidase Cit P450 
Bacterioferritin     RNR-R2 MMOH ∆9 Desaturase 
HEME 
a) 
b) 
E ;  E-X-X-H 
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Figure 5: catalytic cycle of HRP. In this mechanism, the enzyme reacts with one equivalent of H2O2 to 
give compound I, a porphyrin pi-cation radical containing FeIV. This is a two-electron oxidation/reduction 
reaction where H2O2 is reduced to water and the enzyme is oxidised. One oxidizing equivalent resides on 
iron, giving the oxy-ferryl (FeIV=O) intermediate. Compound I then oxidizes an organic substrate to give a 
substrate radical (·AH). Compound I undergoes a second one-electron oxidation reaction yielding 
compound II, which contains an oxy-ferryl center coordinated to a normal (dianionic) porphyrin ligand. 
Finally, compound II, is reduced back to the native ferric state with concomitant one-electron substrate 
oxidation. The overall charge on the resting state and  compound I is +1, while compound II is neutral. 
 
 
HRP contains ferriprotoporphyrin IX as the heme prosthetic group, which is attached 
to the enzyme at His170 (the proximal histidine residue) by a coordinative bond between 
the histidine side chain Nε atom and the heme iron atom. The second axial coordination 
site (on the so-called distal side of the heme plane) is unoccupied in the resting state of 
the enzyme but available to hydrogen peroxide during enzyme turnover (Figure 6). Small 
molecules such as carbon monoxide, cyanide, fluoride and azide bind to the heme iron 
atom at this distal site giving six-coordinate peroxidase complexes. Some bind only in 
their protonated forms, which are stabilized through hydrogen bonded interactions with 
the distal heme pocket amino acid side chains of Arg38 (the distal arginine) and His42 (the 
distal histidine). The Nδ of the proximal heme ligand His170 is seen to be hydrogen 
bonded to Asp247 [17]. The presence of a strong hydrogen bond is believed to increase the 
basicity of His170 relative to the globins, thus helping to stabilize high oxidation state 
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intermediates by a charge relay system while helping to maintain the heme in a five-
coordinate state. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: key amino acid residues in the heme-binding region of HRP. The heme group and heme iron 
atom are shown in red, the remaining residues in atom colours. His170, the proximal histidine residue, is 
coordinated to the heme iron atom whereas the corresponding distal coordination site above the plane of the 
heme is vacant.  
 
 
In the distal site, the Arg38 residue is responsible for the charge stabilization in the 
precursor enzyme-substrate complex of compound I and is involved in the cleavage of 
the O-O bond of peroxide. His42 is thought to promote the formation of Compound I by 
acting as a general acid-base catalyst that (i) deprotonates H2O2, facilitating the formation 
of a ferric peroxide (Fe-OOH) complex and (ii) subsequently transfers the proton to the 
distal oxygen of the ferric peroxide complex in the dioxygen bond cleavage step [18].  
This catalytic sequence produces the HRP ferryl porphyrin radical cation species 
(P+·FeIV=O) known as Compound I. A network of hydrogen bonds is thought to assist the 
distal histidine in its catalytic role (Figure 7). 
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Figure 7: proposed catalytic cycle for plan peroxidase oxidation of small phenolic substates. 
 
1.1.1.b Cytochrome P450 
The cytochrome P450 superfamily (CYP) is a large and diverse group of enzymes. 
The function of most CYP enzymes is to catalyze the oxidation of organic substances. 
The substrates of CYP enzymes include metabolic intermediates such as lipids and 
steroidal hormones, as well as xenobiotic substances such as drugs and other toxic 
chemicals. CYPs are the major enzymes involved in drug metabolism and bioactivation, 
accounting for ~75% of the total metabolism.  
The most common reaction catalyzed by cytochromes P450 is a monooxygenase 
reaction, e.g., insertion of one atom of oxygen into an organic substrate (RH) while the 
other oxygen atom is reduced to water: 
RH + O2 + 2H+ + 2e– → ROH + H2O 
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Cytochrome P450cam originally from Pseudomonas putida has been used as a model 
for many cytochromes P450 and was the first cytochrome P450 three-dimensional protein 
structure solved by X-ray crystallography (Figure 8). This enzyme is part of a camphor-
hydroxylating catalytic cycle consisting of two electron transfer steps from 
putidaredoxin, a 2Fe-2S cluster-containing protein cofactor.  
 
 
 
 
 
 
 
 
 
Figure 8: active site in cytP450. C357 and protoporphyrin IX are depicted in a bold and stick 
representation. 
 
All P450 enzymes utilize the sulfhydryl group of a cysteine residue as the proximal 
ligand for the heme. In addition, P450s further stabilizes the heme through a few salt-
bridges between basic residues and the heme proprionates. The heme group in P450 is 
buried in the interior of the enzyme unlike peroxidases or cytochromes where at least one 
heme edge in exposed to the surface. The proximal side of the heme is closer to the 
protein surface and thought to be the docking site for P450’s redox partner. 
Most P450 enzymes share similar chemistry and thus can be described with general 
catalytic reaction cycle shown in Figure 9. The resting state of P450 has a ferric heme 
with a water (or hydroxyl) as the sixth ligand. The binding of a substrate to a P450 causes 
a lowering of the redox potential by approximately 100 mV, which makes the transfer of 
an electron favourable from its redox partner, NADH or NADPH. This is accompanied 
by a change in the spin state of the haem iron at the active site. It has also been suggested 
that the binding of the substrate brings about a conformational change in the enzyme 
which triggers an interaction with the redox component. The next stage in the cycle is the 
reduction of the Fe3+ ion by an electron transfered from NAD(P)H via an electron transfer 
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chain. Oxygen binds the ferrous ion to give a ferric-superoxide species. The second 
electron reduces Fe3+-O2¯  to a ferric-peroxy species (alternatively a ferrous-superoxide 
species). Protons are needed to assist in the dioxygen bond cleavage which results in a 
leaving of one oxygen as water and formation of the oxyferryl species. The following 
step is believed to be the extraction of a hydrogen atom from the substrate by this high 
valent iron species forming a substrate radical, which leads to product via an oxygen 
rebound mechanism. An alternative route for mono-oxygenation is via the “peroxide 
shunt”: interaction with single-oxygen donors such as peroxides and hypochlorites can 
lead directly to the formation of the iron-oxo intermediate, allowing the catalytic cycle to 
be completed without going through initial steps [19].  
 
Figura 9:.catalytic cycle of cytP450. 
 
 
1.2 Metalloprotein design 
Many efforts have been devoted to understanding the structure and function of 
metalloproteins, and the ultimate test is to use this knowledge to design new systems that 
reproduce the structures and functions of native metalloproteins [20-22]. Metalloprotein 
design is not just an intellectual exercise that duplicates biochemical and biophysical 
studies of native metalloproteins. This “bottom-up” approach can also elucidate structural 
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features that may remain hidden in those studies. Whereas biochemical and biophysical 
studies mostly reveal individual features that result in a loss of function, design requires 
the incorporation of all the structural features needed to attain a function. Equipped with 
insights from design processes, it may be possible to design new metalloproteins with 
improved properties such as higher stability and greater efficiency, or to impart them 
with functions not found in nature, for use in an even wider range of biotechnological and 
pharmaceutical applications. Metalloprotein design, however, has proven to be more 
challenging than the design of non-metalloproteins. Both fields require the issue of 
polypeptide design to be addressed, but metalloprotein design involves metal ions, which 
are much larger in number than amino acids, and geometries that are much more variable. 
Conversely, most metal-binding sites are highly chromatic and display distinctive 
magnetic properties, making it easier to characterize the designed metalloprotein using 
metal-based spectroscopic techniques rather than X-ray crystallography or nuclear 
magnetic resonance (NMR), thus shortening design cycles. Therefore, the field of 
metalloprotein design has enjoyed much success recently, owing to advances in 
biophysical, computational and structural biology. The field is also progressing from 
purely structural to more functional designs, and from the design of the primary 
coordination sphere to that of the secondary coordination sphere and beyond.  
The purest and most challenging form of metalloprotein design is de novo design, or 
design “from scratch”. De novo design of a metalloprotein involves constructing a 
polypeptide sequence that is not directly related to any natural protein and that folds 
precisely into a defined three dimensional structure that binds a metal ion [23]. 
The protein design process can be divided into two steps: the design of overall 
scaffold and the design of active sites. One of the most exciting advances in the protein 
design field is the successful de novo design of α-helical bundles [24-26]. Recently, 
important progress has also been made in the de novo design of other scaffolds [27-29]. 
Equally exciting results have been obtained in engineering active sites into those de novo 
designed scaffolds, such as the α-helical bundles [30-33].  
Although the design of the overall scaffold and the active sites are linked, it is helpful 
to distinguish these two steps because our knowledge about each step is limited at this 
early stage of protein design. For example, when learning how to design protein active 
sites, we may choose to use de novo designed scaffolds made in the laboratory or native 
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scaffolds provided by nature. Design of active sites in de novo designed scaffolds 
represents the ultimate goal of protein design and is considered de novo design in its 
purest and most challenging term. A recent evaluation of more than 38200 structures in 
the Protein Data Bank indicates that they can be classified into ~1200 different scaffolds 
[34]. This analysis is consistent with the observation that the same protein scaffolds, such 
as triosephosphate isomerase (TIM) barrels, α helical bundles, and Greek key β barrels, 
are used many times in different proteins, with different active sites crafted into the same 
scaffold. Therefore, nature is good at using a limited number of scaffolds to design 
proteins for various functions. Learning this “trick” is an important part of the protein 
design process. While de novo designed helical bundles are one of the most common 
scaffolds and thus an excellent choice for active site design, few successful examples of 
other de novo designed scaffolds have been reported. The design of active sites into 
native scaffolds offers more scaffold choices and thus presents more opportunity to test 
our knowledge and to build proteins with novel properties. Most native scaffolds have 
high thermodynamic stability and extraordinary tolerance for residue substitution, 
deletion, and insertion. These properties allow more drastic changes of the native 
scaffolds and make active site design more likely to succeed. The resulting designed 
protein can more often assume globular rather than molten globular forms and thus is 
more amenable to spectroscopic and X-ray crystallographic characterization. Moreover, 
years of research in molecular biology, biochemistry, and biophysics make the 
construction, purification, and characterization of proteins with characteristic scaffolds a 
common laboratory practice. As the understanding of protein structure improves, de novo 
designed proteins will become more attractive as scaffolds. Until then, working with 
existing native scaffolds affords equal advantages. Perhaps the strongest argument for 
designing metalloproteins by using native scaffolds is that nature uses a similar approach 
- the same scaffold is often seen in numerous proteins with diverse metal-binding motifs 
and functions, suggesting that these native scaffolds are robust and modifiable. For 
example, the β-barrel fold has been shown to be used by ~600 types of protein, with 
diverse functions such as oxidase, reductase, amylase and dismutase activities. 
Discovering how nature is able to use the same scaffold to design a variety of metal-
binding sites is an important goal of metalloprotein design. 
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Biochemical techniques, such as site-directed mutagenesis, have been used 
extensively to study the function of metalloproteins. The loss of function accompanied by 
certain mutations (usually to highly conserved residues) allows the identification of 
residues essential for function. Although serving a different purpose, the same 
mutagenesis techniques can be used in metalloprotein design to impart new function into 
a protein scaffold by introducing residues that bind metal ions. This can be accomplished 
through the redesign of existing metal-binding sites to introduce novel functionality, the 
introduction of mononuclear metal-binding sites into proteins that do not bind metal ions 
natively, or the introduction of homonuclear or heteronuclear metal-binding sites into 
proteins. Design is often aided by empirical approaches based on prior knowledge and 
experience, the use of computer programs (rational design) or combinatorial selections. 
Although these approaches have been relatively successful in designing metalloproteins, 
it is still difficult to design certain metalloproteins, especially functional ones, owing to 
the large number of potential interactions within the active site of a metalloenzyme. In 
this case, combinatorial design and directed evolution of new metalloenzymes is another 
powerful method. 
An appropriate analogue simulates or achieves the coordination sphere composition 
and stereochemistry of the native site. A structural analogue allows deduction of site 
characteristics common to the site and itself by possessing sufficiently high adherence to 
the indicated features. A functional analogue sustains a stoichiometric, or better, a 
catalytic reaction which transforms substrate to product as does the enzyme, albeit at a 
different rate and not necessarily with the natural stereochemical outcome. A functional 
model is not ineluctably a structural model, but, ideally, a high-fidelity structural model 
is a functional model. As implied in the Figure 10, construction of an analogue complex 
can be an iterative process, until the desired level of similarity with the site is achieved. 
Because of the complexity of protein folding, even with small model proteins, new 
proteins will generally be obtained only through considerable trial and error: the initial 
design is conceived and synthesized, then structurally and biophysically characterized.  
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Figure 10: general schematic of a de-novo protein design or protein-engineering cycle. 
 
In metalloenzymes, catalytic activity and stability of the metal cofactors are regulated 
by specific interactions with amino acid residues in the protein cavities [35-36]. First, the 
protein matrix shapes the primary coordination shell of the metal ion dictating the 
composition, number, and geometry of the ligands. In addition, residues in the second 
shell, the immediate surroundings of the primary coordination sphere, influence a variety 
of structural and chemical facets, including hydrogen-bonding interactions to the ligands, 
pKa values of ligand groups, and the control of the metal center oxidation state and redox 
potential. Finally, neighbouring side chains also exert steric and chemical controls over 
the ability of the metal ion(s) to bind or discriminate the substrate and to accommodate 
conformational changes [35-36]. Thus, it is clearly evident that the structures of the 
metal-binding sites in proteins reflect a delicate interplay between opposing requirements 
for tight binding of the cofactor, which drives toward static, coordinately saturated 
geometries, versus function, which requires the cofactor to be coordinately unsaturated, 
sometimes with unusual geometries, and properly positioned for binding substrates and 
undergoing dynamic changes in configuration during catalysis. Therefore, numerous 
efforts are continuously aimed to a better understanding of the factors that modulate 
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metalloprotein activity, with the ultimate goal of developing metalloenzymes with novel 
structures and functions. 
 
 
1.3 Peptide-based metalloprotein analogues  
The study of natural metalloenzymes and related mutants, generated by site-directed 
mutagenesis, as well as the study of smaller complexes containing designed organic 
ligands, has clarified several fundamental properties of natural proteins [37-41]. For 
example, mutation studies have shown that modest changes brought to an enzyme’s 
structure can have large effects on its catalytic properties. Chemical modification of a 
single amino acid residue can change the fundamental activity of the enzyme, and a 
single site mutation can alter its enantioselectivity [37]. Even though impressive progress 
has been made with both strategies, the study of large proteins may be hampered by their 
extreme complexity, and it is often difficult to design small molecule complexes that can 
bind multiple substrates and metal ions in water. Therefore, due to the inherent 
complexity of enzyme structure, tailoring synthetic biocatalysts still is a daunting 
challenge, since it requires the development of sophisticated molecular architectures that 
distil the quintessential elements believed to be responsible for the activities. This 
problem has been recently approached with the stratagem of synthesizing scaled-down 
polypeptides that self-assemble with metal ions and cofactors to form metalloprotein 
mimetics. These structures are simple enough to avoid much of the ambiguity of 
interpretation associated with large proteins, and yet should simultaneously be of 
sufficient size and chemical diversity to allow the construction of functional sites. Thus, 
these mimetics - which stand at the crossroads of traditional small molecule models and 
large proteins - should allow one first to understand the properties of natural proteins, and 
second to construct economical catalysts and sensing devices. The development of 
peptide-based models takes advantage of recent progress in both design and synthesis of 
peptides and proteins. Relatively simple rules have been established for the development 
of stable and well-defined protein and metalloprotein models, using either minimalist 
design strategies or de novo design approach [42-43]. The Bioinorganic Chemistry 
Research Group, where this work was carried out, has approached the challenge of 
reproducing metalloprotein active sites using both strategies. In particular, the attention is 
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centerd on iron-containing proteins, developing models for heme-proteins 
(Mimochromes) [7, 44-49] and di-iron-oxo proteins DFs (DF represents due ferri, Italian 
for “two iron”, “di-iron”) [9-11, 50-58]. All these models have a common characteristic: 
they are fully or partially C2-symmetric systems, intended to reproduce the quasi-
symmetrical structure of a metalloprotein. The use of C2 symmetry is particularly 
advantageous: it simplifies the design, synthesis and structural characterization of the 
models, even though it leaves open the problem of possible diastereomeric forms. 
A miniaturization process was applied in the development of the first class of 
artificial metalloproteins. By a detailed analysis of the crystal structures of natural heme-
proteins, a minimum set of constituents necessary for an accurate reconstruction of the 
active sites’ structures was successfully selected. In particular, the type and number of 
constituents to be assembled were selected to include all the elements of the primary and 
secondary coordination shell to the metal. The results obtained on this class of 
metalloprotein models indicated that these simple, structurally defined systems provide a 
good opportunity for investigating how changes in the polarity, solvent accessibility, and 
electrostatic potential surrounding the active site affect its electrochemical midpoint 
potential and chemical reactivity.  These molecules are very promising systems in the 
field of metalloenzymes model compounds: they have a high degree of functional 
similarity with respect to their natural counterparts, and they are excellent scaffolds to 
engineer new peptide-metal complexes, with different metal cofactors. 
In the field of di-iron-oxo proteins, a de novo design approach for the development of 
artificial models was used. In particular, the DF (Due Ferri) family of artificial proteins 
was designed, as models of diiron and dimanganese metalloproteins, with the aim of 
reproducing the functional specificity of the natural systems and with the ultimate goal of 
developing new metalloenzymes with functions unprecedented in nature. The DF 
proteins were developed through an iterative process of design and rigorous 
characterization, which allowed to diagnose the problems associated with the initial 
models, and to improve the models in subsequent designs. Thus, the problem of 
designing the DF family was approached through several steps. The first involved the 
design of stable, uniquely folded proteins that contain the metal binding site; the first 
model DF1, which was an antiparallel dimer of helix-loop-helix motif, was able to bind 
the dimetal cofactor near the center of the structure [50-52]. To improve the functional 
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properties of the initial model, DF1 was subjected to several changes in the sequence, as 
well in the loop structure (DF1 and DF2 subsets) [53-58]. The design further evolved 
with the construction of versions in which the four helices are distinct chains that come 
together by non-covalent self assembly (DFtet) [59-61]. Each class has different 
advantages. For example, the symmetric nature of the dimeric derivatives simplifies 
interpretation of data, whereas analogues of the four-chain DFtet constructs can be mixed 
and matched to allow easy generation of combinatorial diversity.  
In this thesis, we will report all the results we obtained in protein design, in particular 
in the class of di-iron-oxo-analogues, presenting the characterization and the catalytic 
activity of the last analogue, DF3; on the basis of positive results obtained in the class of 
peptide-based heme-models Mimochromes, we also report design and synthesis of a new 
class of models, called MPs (Mini-Peroxidases), which encompass structural and 
functional features of both classes and that should be able to activate hydrogen peroxide 
to give HRP-like catalytic process.  
 
 
1.3.1 From natural to artificial di-iron-oxo-systems: DFs 
DFs are simplified models of di-iron proteins and were designed after an analysis of 
the structures of several natural di-iron enzymes, such as ferritin, bacterioferritin, 
rubrerythrin, ribonucleotide reducatse R2 subunit, ∆9ACP desaturase, and the catalytic 
subunit of methane monooxygenase. The homodimeric subset of the DF family consists 
of helix–loop–helix hairpins that dimerize to form an antiparallel four-helix bundle. It 
provides a four Glu, two His site in the correct geometry for binding a dinuclear metal 
center: two glutamic acids bridge both metal ions, while the other two carboxylates 
interact with a single metal ion in a monodentate or bidentate chelating interaction; the 
two His residues at position i+3 relative to the two bridging Glu side chains form 
additional monodentate ligands. The absence of a His ligand in the other two helices 
leaves two adjacent coordination sites available for interaction with exogenous ligands. 
Second-shell interactions are also important for maintaining the structures of metal-
binding sites and for tuning their properties: the nonbridging Glu carboxylates form a 
hydrogen bond with a Tyr side chain of a neighboring helix; similarly, an Asp residue 
forms a hydrogen bond with the imidazole Nε of a His ligand (Figure 11).  
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Figure 11: structure of the active site of di-Zn(II)-DF3. Second-shell hydrogen bonds between Tyr17 and 
Glu10’, and between Asp35 and His39’ are indicated as dashed lines (prime numbering refer to residues 
belonging to symmetry-related chains). 
 
The first model, DF1, was designed for maximal stability [51]. Thus, the interior of 
the protein was efficiently packed with a large number of hydrophobic side chains, 
resulting in a high degree of conformational stability. The structural characterization 
showed DF1 to be an excellent structural model of di-iron proteins. It adopts a folded, 
native-like conformation in the apo and metal-bound forms and was able to bind metal 
ions such as Zn(II), Co(II), and Mn(II) in the correct geometry and stoichiometry [51-52]. 
Unfortunately, DF1 was not able to support any function, because access to its active site 
was hampered by the compact hydrophobic core around the metal center. To improve the 
functional properties of the initial model, subsequent work focused on opening the cleft 
for binding small ligands to the dimetal center. DF1 was thus subjected to several 
changes in the sequence, as well as in the loop structure (DF1 and DF2 subsets) [53-58]. 
In particular, substitution of Leu13 and Leu13’ in DF1 with smaller side chain amino acids, 
such as Ala and Gly, afforded a cavity large enough to allow access of small molecules to 
the metal center. The L13G-DF1 [57] and L13A-DF1 [58] variants, as well as the DF2 
subset [53-54, 56], bind exogenous ligands, such as phenol and acetate, and display 
ferroxidase activity. However, optimization of the catalytic activity required further 
changes in the second-shell ligands. Modeling suggested that residues at positions 9 and 
13 play a critical role for the accessibility to the metal site. Combinatorial studies on the 
DFtet subset (a heterotetrameric system consisting of four disconnected helices that came 
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together by noncovalent self-assembly) resulted in the selection of G4-DFtet (a variant 
with Gly residues at positions 9 and 13) as the best candidate for function [59-61]. 
Unfortunately, structural data were not obtainable for the DFtet subset, and it was not 
possible to correlate active-site structure and activity. Figure 12 illustrates the amino acid 
sequence of all DFs analogues. 
 
 
 
 
 
 
 
 
Figure 12: sequence alignment of DF family proteins respect to the prototype DF1. The liganding 
residues are highlighted in green, second-shell ligands in pink, and residues involved in the active site 
access in orange. a) DF2 subset and b) DFtet subset: the residues in the A-subunits that were varied are 
underlined. 
 
We ultimately focused on the much easier to characterize symmetric helix–loop–helix 
dimer. DF3 encompasses all the main features thought to be crucial for function, which 
are (i) Gly residues at positions 9 and 13 of the sequence and (ii) a redesigned ‘‘Rose-
like’’ αL–β interhelical loop.  
The new protein shows improved solubility and active-site accessibility, while 
retaining the unique native-like structure, as assessed by NMR structural characterization 
[10]. Most importantly, DF3, with its well-defined active site, displays ferroxidase and 
oxidase activity.  
In this thesis, we describe the main spectroscopic and catalytic properties of DF3. 
Different spectroscopic techniques were used to fully characterize DF3 and demonstrate 
its capability to form stable complexes with different metal ions. Binding of an 
exogenous ligand (azide) was also analyzed to prove the enhanced accessibility to the di-
metal site in DF3, with respect to previously characterized DFs. All the spectroscopic and 
structural features reported herein help to correlate structure with function in de novo 
designed metalloproteins. 
a)   f g  a b c d e f g a b c  d e  f  g a b c d e f  g b c d e f  ga b  cde f  g a b c d ef g  a b cd e f 
 
DF1           DYLRELLKLELQ L I    KQYREALE YV---KL---------PVLA KILEDEEKHIEWLETILG     
DF2       MDYLRELYKLEQQAM KL YREASE RV---GD---------PVLA KILEDEEKHIEWLETILG 
DF2t      MDYLRELYKLEQQAM KL YREASE K---ARN-PEKKSVLQKILEDEEKHIEWLETILG 
 
b)     g a b c d e f g   a b c d e f  g a  b c   d e  f  g  a b c d e f g  a b c d 
 
DF1      DY  LRELLK LELQ   L I    KQYREALEY V 
    A              K LKELKSK  LKELLK LELQ  A I    KQYKELKAE LKEL 
    Aa             K LKELKSE   LKELLK  LELQ  A I    KQFKELKAE LKEL 
    Ab             K LKKLKSR  LKKLLK LELQ  A I    HQYKKLKARLKKL 
 
DF1      PV  LAKI LE DEEK   HI EWLET I LG 
    B                    ELLLESE   LE KI LE DEER   HI EWLEKLE AKLKEL 
Chapter 1 - Natural and artificial metalloproteins  
 
 
 - 23 - 
1.3.2 From natural to artificial heme-systems: Mimochromes 
Our laboratory has approached the challenge of constructing heme-protein models 
using a miniaturization process [44]. A miniaturized heme-protein is a peptide-based 
model which contains a minimum set of constituents necessary for (i) an accurate 
reconstruction of a well-defined structure and (ii) a fine-tuned reproduction of a defined 
function. This strategy leads to the development of a class of miniaturized heme-proteins, 
named Mimochromes [45-48]. The main features of Mimochromes are the covalent 
structure and a well-defined helical conformation of the peptide chains linked to the 
deuteroporphyrin ring, even in the absence of metal ion coordination. The schematic 
structure of Mimochromes is reported in Figure 13. A minimalist approach was used to 
design short peptide sequences which could serve partly the same functions of the protein 
chain in the natural heme-proteins. A detailed analysis of heme-protein structures showed 
that the prosthetic group in natural heme-proteins is strongly kept inside the protein 
structure by a large number of interactions. These interactions were replaced in 
Mimochromes by a few strong local constraints. The prototype molecule, Mimochrome I, 
was patterned on the F helix of hemoglobin β-chain [63]. The smallest sequence, required 
for a complete coating of one face of the heme, was identified in a nine-residue peptide, 
which contains a central His residue to ligate the heme iron. Leu residues were placed at 
positions i-4 and i+4 relative to the His to hydrophobically interact with the heme 
macrocycle. Two copies of the peptide were covalently linked to the porphyrin propionic 
groups through the ε-amino function of Lys8 obtaining a pseudo-C2-symmetric dimer 
[45].   
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Figure 13: schematic representation of the chemical structures of Mimochromes. The covalent linked 
K residue is indicated in italic, and the axial ligand is indicated in bold. 
 
The spectroscopic and structural characterization of Mimochrome I indicated that it 
binds cobalt and iron in a low-spin bis-His-ligated state, as envisioned in the design. 
Interestingly, the insertion of metal ion into the porphyrin ring gave two diastereomeric 
forms, differing for the configuration around the metal ion: the flexibility of the linker 
between the peptide and the deuteroporphyrin ring allows each peptide chain to be 
positioned either above or below the porphyrin plane (Figure 14). 
 
Figure 14: average molecular structures of Co(III)-Mimochrome I Λ and ∆ isomers, as obtained from 
NMR experimental data and RMD calculations. 
 
The information derived from Mimochrome I was fruitfully applied for improving the 
design, which focused on molecules with longer (14 residue) sequences, modeled in both 
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α-helical (residues 1-10) and extended (C-terminal part) conformations [47]. 
Interestingly, a unique diastereomer was stabilized in both iron and cobalt derivatives. 
Further, the newly developed molecules show a higher helix content with respect to 
Mimochrome I, even in water. These findings confirm the correctness of the design and 
show that all the changes made in the sequence not only stabilize a single topology of the 
peptide chains around the porphyrin, but also favor helix formation with respect to 
Mimochrome I. The last achievement was the design of molecules capable of stabilizing 
a five-coordinate iron (II) complex, providing an empty site available for catalyzing 
oxidation reactions [8].  
In particular Mimochrome VI (Figure 15) is the result of a refinement procedure of 
design, whose starting point is represented by Mimo II and Mimo IV; they both are 
examples of bis-His cobalt porphyrin-peptide conjugate. The first is a bis-
tetradecapeptide-porphyrin conjugate, and the latter is a bis-nonapeptide-porphyrin 
conjugate (see Figure 13). Both are pseudo-C2 symmetrical systems. The sequences of 
Mimochrome II and IV were combined to construct an unsymmetrical five-coordinate 
mono-histidine model. The primary structure contains a histidine (His6) on the 
tetradecapeptide chain (derived from the sequence of Mimochrome II), as potential axial 
ligand to the metal (proximal face), and a serine (Ser6) on the decapeptide chain (derived 
from the sequence of Mimochrome IV) in order to create a cavity near the metal site 
(distal face). Some substitutions from the sequences of Mimochrome II and IV were 
introduced to further stabilize the secondary and tertiary structure. Similarly to other 
Mimochromes, both peptide chains are covalently linked to the porphyrin propionate 
through the Lys9 side chains. In terms of secondary structure, the tetradecapeptide was 
designed to adopt: (i) a short helical conformation (residues 1-9), (ii) a γαD loop (residues 
10-11), and (iii) a short β-strand (residues 12-14) that folds back (through the loop) to 
interact with the helical part; (iv) the decapeptide adopts a helical conformation (residues 
1-8). The tertiary structure can be described as a sandwich, which is characteristic of 
Mimochrome class of molecules. The two peptide chains embrace the metalloporphyrin; 
the helical segments are antiparallel to each other and the helix axes are about parallel to 
the porphyrin plane. Stabilization of the tertiary structure was contributed by inter-chain 
ion-pairs between the carboxylate side chains of glutammate residues (Glu2) on one helix 
and the guanidine groups of arginines (Arg10) on the other helix. The positive Arg10 and 
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the negative Glu2 at the C-terminal and N-terminal ends, respectively, with opposite sign 
relative to the helix dipole, may also provide stabilization of the secondary structure. 
Finally, several glutamines (Gln3, Gln4, Gln8) and a serine (Ser7) were introduced in the 
solvent exposed positions to convey water solubility. 
 
Figure 15: schematic representation of Fe(III)-Mimochrome VI model structure. 
All the spectroscopic and functional properties indicate that Fe(III)-Mimochrome VI 
is an efficient five-coordinate heme-protein model, which houses a peroxidase-like active 
site. Mimochrome VI peptide framework, despite its small structure (a total of 24 amino 
acid residues), confers higher efficiency to the porphyrin cofactor, compared to other 
peroxidase mimics. Several important outcomes deserve highlighting:  
(i) Fe(III)-Mimochrome VI efficiently catalyzes the oxidation reaction of different 
substrates, such as ABTS and guaiacol, by activating H2O2 and efficiently catalyzes 
the nitration of phenols; 
 (ii) Fe(III)-Mimochrome VI displays a very high specific activity (104 mol·mg-1·s-1 for 
ABTS oxidation), with respect to highly purified HRPs (91 mol·mg-1·s-1 for ABTS 
oxidation at pH=4.6); these value highlights both its high catalytic efficiency and 
small molecular mass, compared to natural peroxidases that contain more than 300 
amino acid residues;  
(iii) Fe(III)-Mimochrome VI exhibits multiple turnover kinetics: more than 4000 
turnovers within 10 min were observed in the ABTS oxidation.  
All these features indicate that Fe(III)-Mimochrome VI is an attractive, low-
molecular weight heme enzyme, which could serve as an excellent scaffold to further 
develop designed heme-based biocatalysts. 
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1.3.3 MPs, a new class of four-helix bundle heme proteins 
Another goal of the current work was to introduce peroxidase-like activity into a new 
class of four-helix bundle heme-models: MPs (Miniperoxidases), which encompass 
structural and functional features of iron-oxo- and heme-proteins and that should be able 
to activate hydrogen peroxide to give HRP-like catalytic process.  
Among heme-proteins, peroxidases catalyze a variety of oxidation reactions by using 
H2O2 [64]. These outstanding biocatalysts are able to catalyze reactions such as 
heteroatom oxidation (N and S-oxidation), epoxidation, hydroxylation, and the oxidation 
of alcohols and indole, often giving high yields and enantiomeric excess values. 
Peroxidases are hemoenzymes with a wide range of applications, from fine chemical 
synthesis to environmental biocatalysis. For example, they can be used for treatment of 
industrial waste waters: phenols, which are important pollutants, can be removed by 
enzyme-catalyzed polymerization using HRP. Thus phenols are oxidized to phenoxy 
radicals, which participate in reactions where are produced polymers and oligomers that 
are less toxic than phenols. Furthermore, peroxidases can be an alternative option of a 
number of harsh chemicals, eliminating harsh reaction conditions and use low-
environmental impact solvents and oxidants. There are many investigations about the use 
of peroxidase in many manufacturing processes like adhesives, computer chips, car parts, 
and linings of drums and cans. These enzymes are very appealing for laboratory or 
industrial oxidation reactions, because they have high activity, toward a wide range of 
substrates. However, their high production costs and instability during catalysis limit 
their potential applications. One solution to this problem would be the use of simpler 
synthetic peroxidases with improved stability and efficiency. 
Many attempts have been devoted to obtaining novel molecules bearing the function 
of peroxidase-like activity [65-69].  For example, variants of myoglobin have been 
utilized to compare the structure-activity relationships with peroxidases [70]. Although 
natural heme-proteins can be good candidates to study the function of peroxidases, it is 
also significantly desired to construct appropriate model proteins with a simplified 
sequence in a minimal size. So far, many miniaturized heme-proteins have been designed 
and synthesized, such as 4α- or 2α-helix peptides binding heme non-covalently [65-69] 
and 2α- or βα-structures covalently attached to heme [71-72]. Since these artificial 
proteins include a heme iron coordinated by two His residues, they are suitable to be 
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applied to a redox function, but not exactly appropriate for the peroxidase-like activity. 
This is because two His residues of natural peroxidases are in charge of distinct roles at 
either the hydrophobic proximal site or the hydrophilic distal site around the porphyrin 
molecule. The proximal His coordinates to heme iron strongly, whereas the distal His 
plays roles in deprotonation/ protonation of substrates such as hydrogen peroxide 
involved in the catalytic reaction [73].  
So, in contrast to the numerous synthetic heme-protiens that are greatly stabilized by 
bis-His coordination of the iron center, de novo proteins with five-coordinated heme 
complexes have not been extensively reported. 
A series of α-helical peptides covalently linked to heme were studied by Mihara and 
co-workers [74]. In a recent paper they reported the development of two three-helix 
bundle proteins, 3α-H9 and 3α-H12, covalently bound to meso-heme IX as models of 
peroxidases [74]. The distal His ligand was placed in different positions within the two 
systems to regulate six- or five-coordination of the heme iron. The two molecules showed 
different activities toward the oxidation of o-methoxyphenol to tetra-guaiacol using 
hydrogen peroxide as oxidant. In particular, a good correlation was found between the 
coordination states of the heme and the catalytic efficiency of the systems, i.e. the 
molecule containing a higher content of five-coordination showed the best activity. 
However, the accessibility of hydrogen peroxide and its destructive effect toward the 
heme should be carefully balanced in order to enhance the activity.  
Another example is provided by Hecht and co-workers, who used the binary 
patterning approach in the design of semi-random libraries of peptides, screened for their 
ability to bind heme [75-77]. Among 30 binary code sequences tested, 15 were shown to 
bind heme with a broad range of affinities and with spectroscopic features resembling 
those of natural cytochromes [75]. In a subsequent work, it was demonstrated that several 
of the “binary code” proteins possess peroxidase activity at rates rivaling natural 
peroxidases [76]. Eight “binary pattern” heme-proteins, derived from two combinatorial 
libraries, were also assessed for carbon monoxide binding [77]. The CO binding affinities 
for all proteins were similar to that of myoglobin, with dissociation constants in the 
nanomolar range. Resonance Raman studies indicated that none of the eight “binary 
code” proteins contribute an H-bond donor or a lone pair for interaction with the CO. 
Such interactions are often observed in the CO adducts of natural heme-proteins [77]; the 
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lack of explicit design causes these “binary code” proteins unable to make specific 
directional interactions with bound ligands. All these results are particularly encouraging 
because they suggest that “semi-random” libraries may produce artificial heme-proteins 
which may have catalytic and binding activities. Nevertheless, the construction of 
specific desired functionality within these artificial heme-proteins requires explicit 
design, genetic selections, or both. 
Important models in which peptide chains are covalently linked to the heme are 
microperoxidases. The term microperoxidases is used to define the range of heme-
peptide fragments that can be obtained by proteolytic digestion of cytochromes c. The 
microperoxidases framework consists of a small peptide fragment, containing the Cys-
(Xaa)2-Cys motif, covalently linked to the heme c through thioether linkages with the two 
Cys residues. The amino acid sequence of the polypeptide chain in microperoxidases is 
numbered according to that of the parent cyrochrome c; thus, the two Cys residues 
occupy positions 14 and 17 of the peptide chain. Selective proteolysis of cytochrome c 
affords various microperoxidases, differing in the peptide chain length [78-79]. The 
nomenclature used to describe microperoxidases is shown in Figure 16. Several methods 
were reported for the preparation of microperoxidases starting from cytochrome c. 
Generally, the trypsin digestion of cytochrome c leads to MP8 while pepsin degradation 
gives MP11 [80]. 
 
   a)      b) 
Figure 16: microperoxidases. a) Schematic representation of the microperoxidase framework, depicted as 
six-coordinated aqua complex; the sequence of MP8 is indicated; b) some of the various microperoxidase 
fragments that can be obtained by selective proteolysis of cytochrome c, together with covalently modified 
derivatives. 
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The structure of microperoxidases is very appealing, since these small molecules 
contain the minimal requirements for a heme-protein mimetic. They bear a His residue at 
position 18, which coordinates the iron and acts as proximal ligand. In addition, the sixth 
coordination site is open, thus allowing the accommodation of exogenous ligands or 
substrates. Owing to these properties, microperoxidases are very useful models for the 
analysis of the spectral, magnetic, ligand-exchange, and catalytic properties of heme-
proteins. One of the major drawbacks in the use of microperoxidases is that they show a 
tendency to aggregate in aqueous solution [80]. This phenomenon limits the practical 
applications of these heme-peptide fragments, since they can exist in solution as a 
mixture of multiple species.  
Despite the wide variety of reactions they catalyze, the applications of 
microperoxidases as minicatalysts are limited by their low stability under catalytic 
conditions. Accessibility of the distal site causes degradation of the porphyrin ring during 
catalysis, either by the direct action of H2O2 or by intermolecular reactions with another 
active iron-oxo species. However, their stability is higher than simple protoporphyrin 
systems, thus indicating that the presence of the small peptide chain can play an 
important protective role toward the bleaching of the catalyst. 
In this work, we tried to introduce peroxidase-like activity in an artificial de novo 
designed class of models, named MPs (MiniPeroxidases), who should present following 
adavantages:  
(i) a stable structure, in wich accommodate the heme-group without loosing the expected 
three-dimensional structure; 
(ii) a steric protection of the porphyrin ring accomplished by the protein moiety, which 
should prevent the rapid degradation of the catalyst during the reaction; 
(iii) a cavity large enough to selectively recognize a defined substrate. 
These novel molecules are simple enough to avoid much of the ambiguity of 
interpretation associated with large proteins, and simultaneously of sufficient size and 
chemical diversity to allow the construction of functional sites. Thus, these mimetics - 
which stand at the crossroads of traditional small molecule models and large proteins - 
should allow to understand the properties of natural proteins and to construct economical 
new synthetic catalysts and sensing devices. 
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2.1 Results 
2.1.1 Design 
DF3 was designed by introducing a phenol-binding site into DF1 scaffold, converting 
it in a phenol oxidase, similar to the natural enzymes alternative oxidase (AOX) and 
plastid terminal oxidase (PTOX) [81-82]. 
The elaboration of phenol oxidase activity in DF3 required expansion of the active 
site cleft to accommodate phenols. Previously, we explored possible solutions to this 
problem in a combinatorial manner through the design of DFtet, which is composed of 
four unconnected helical peptides [60, 62]. Mixing different DFtet peptides produces 
catalysts for the oxidation of 4-aminophenol [62]. However, the complex stoichiometry, 
marginal stability and tendency to undergo ligand-exchange reactions hamper attempts to 
fully characterize the structure and properties of the DFtet assemblies, which led us to 
introduce the corresponding mutations into the more well-characterized DF1 framework 
(Figure 17a). 
Access to the DF1 active site is severely limited by four bulky leucine side chains at 
positions 9 and 13 of each monomer (Figure 17b), each of which is converted to glycine 
in the most active DFtet analog [62]. However, the introduction of helix-destabilizing 
glycine residues and loss of the hydrophobic driving force strongly destabilize the fold of 
the protein. Indeed, a single mutation of Leu13 to glycine destabilizes DF1 by 10.8 kcal· 
mol−1·dimer–1, precluding the introduction of the second glycine residue [53]. To increase 
the conformational stability of the DF scaffold, we modified the sequence of the 
interhelical turn, which adopts an αR-αL-β conformation [52]. Previous attempts to 
redesign the protein to accommodate different turn types [55, 57] were not sufficiently 
successful to provide adequate stability to support the desired multiple glycine mutations. 
Thus, we used the PDB database to derive statistical position-specific propensities for 
this solvent-exposed αR-αL-β turn [57], leading us to change the original Val24-Lys25-
Leu26 of DF1 to Thr24-His25-Asn26 (Figure 17 c-d). In models, His25 appeared capable of 
forming stabilizing hydrogen bonded C-capping interactions of helix 1, while Asn26 
could either form N-capping interactions with helix 2 or with the carbonyl group of Thr24, 
depending on its rotamer. Introduction of this sequence, along with the two leucine-to-
glycine mutations, resulted in a sequence designated DF3 (Figure 17).  
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       Helix 1           loop  Helix 2  
 
 
 
Figure 17: Comparison of DF1 and DF3 structures. a) di-Zn(II)-DF1 crystal structure. b) di-Zn(II)-DF1 
surface representation, displaying the accessibility to the active site and highlighting the different residues 
in position 9 (lime) and 13 (cyan). c) di-Zn(II)-DF1 loop structure. d) di-Zn(II)-DF3 loop structure; N-
capping and C-capping interactions are depicted. e) di-Zn(II)-DF3 surface representation, displaying the 
accessibility to the active site and highlighting the different residues in position 9 (lime) and 13 (cyan). The 
point mutations introduced in proximity of DF3 active site create a cavity large enough to allow substrates 
to approach the metal ions (depicted in magenta in e)). In contrast, the active site is completely buried in 
DF1 b). f) NMR bundle of the best 30 minimized structures for di-Zn(II)-DF3. DF1 and DF3 sequence 
comparison is also reported. Amino acid substitutions in the DF3 sequence are indicated in red. The atomic 
coordinates of di-Zn(II)-DF3 ensembles, chemical shifts and NMR constraints have been deposited in the 
PDB under accession code 2KIK. 
 
 
2.1.2 Synthesis 
The 48 amino acid peptide DF3 was synthesized using solid-phase methods with 9-
fluorenylmethoxycarbonyl protocols. The crude peptide obtained was more than 90% 
pure, as assessed by analytical RP-HPLC, and it was further purified to homogeneity by 
preparative RP-HPLC to a single, symmetric peak. The collected fractions were analyzed 
by analytical RP-HPLC, mixed, lyophilized, and stored at -20 °C. The identity of the 
peptide was further ascertained by matrix-assisted laser desorption ionization time of 
DF1          DYLRELLK 9LELQ 13LIKQYREALEY   -24VKL        PVLAKILEDEEKHIEWLETILG     
 
DF3          DYLRELLK 9GELQ 13GIKQYREALEY   -24THN        PVLAKILEDEEKHIEWLETILG     
a) b) c) 
d) e) f) 
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flight measurements, which confirmed the expected molecular mass (DF3, 5,779 a.m.u. 
calculated, 5,776 ± 5 a.m.u. observed). 
 
 
2.1.3 Structural and physico-chemical characterization 
2.1.3.a NMR studies  
To confirm the structural basis for DF3’s catalytic activity, its NMR solution 
structure was solved using the diamagnetic di-Zn(II) derivative as a surrogate for the 
diferrous form of the protein. An ensemble of 30 refined structures (calculated using 15 
restraints per residue, including 2 × 230 intraresidue, 2 × 185 sequential, 2 × 152 
medium-range, 174 intermonomer and 2 × 47 intramonomer NOEs) was tightly clustered 
(Figure 17f), with a root mean square deviation (r.m.s. deviation) of 0.68 Å for the main 
chain atoms and 1.39 Å for all heavy atoms. The monomer consisted of two α-helices 
connected via an αR-αL-β turn spanning residues 24–26. As expected, the Nε proton of 
the His25 imidazole ring capped helix 1, forming a hydrogen bond to the amide carbonyl 
of residue 22. The side chain of Asn26 formed a hydrogen bond with the carbonyl oxygen 
of Thr24 in approximately 50% of the members of the ensemble (Figure 17d). The 
solution structure of di-Zn(II)-DF3 was nearly identical to the guiding model, which was 
based on di-Mn(II)-L13G-DF1 [58]. The backbone r.m.s. deviation for the bundle 
(residues 4–18, 29–41) was 1.2 Å; for comparison, the r.m.s. deviation between dimers of 
di-Mn(II)-L13G-DF1 in different crystalline environments ranges from approximately 
0.6 to 1.2 Å [58]. The di-metal cofactor, which lied at the bottom of an apolar pocket, had 
vacant ligation sites available to interact with incoming O2 and phenols. The 4-Glu, 2-His 
primary ligand field was stabilized by four second-shell interactions (see Figure 11 in 
Chapter 1), resembling those in native proteins, including a proposed hydrogen bond 
between Tyr280 and the primary ligand Glu273 of AOX [81-82]. The L9G and L13G 
mutations created an active site cleft (Figure 17e), which at its narrowest point matched 
the width of the substrate’s phenyl ring.  
Bulkier substituents at the 3 and 5 positions of a bound phenol could be 
accommodated in wider and more solvent accessible regions of the cavity (Figure 18). 
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Figure 18: model of substrate interaction with DF3 protein. Surface representation of the di-Zn(II)-DF3 
NMR structure with a 3,5-DTBC molecule (violet) bound into the active site access channel. The surface 
associated with the bound 3,5-DTBC is also depicted. 
 
 
2.1.3.b CD studies  
CD spectroscopy was used to analyze the secondary structure of DF3. The far-UV 
CD spectrum of apo-DF3 in 10 mM phosphate buffer, pH 7.0, clearly indicates the 
protein to be in a helical conformation, as designed (Figure 19a). The spectrum shows a 
maximum at 195 nm ([θ]195 = 42,271 deg·cm2·dmol-1·res-1) and minima at 208 nm ([θ]208 
= -20,725 deg·cm2·dmol-1·res-1) and 222 nm ([θ]222 = -22,093 deg·cm2·dmol-1·res-1). All 
these values are consistent with those observed for previous members of the DF family 
[52]. Thus, the changes made in the sequence did not affect the secondary structure of 
DF3. 
DF3 binds divalent metal ions, while retaining its folded helical conformation. CD 
studies allowed us to assess both the effect of metal binding on the DF3 secondary 
structure and the binding stoichiometry. Addition of M(II) ions (M is Mn, Co, and Zn) to 
a solution of apo-DF3 at pH 7 resulted in a small, but measurable, decrease of the band at 
222 nm ([θ]222 decreases to -22,915 deg·cm2·dmol-1·res-1), consistent with an overall 
increase of a-helicity (Figure 19b-d). This finding can be ascribed to the stabilization of 
a metal-bound four-helix bundle [di-M(II)–DF3]. In fact, titration with Na+ ions (which 
are not expected to bind into the four-helix bundle) or with Co(II) under noncoordinating 
conditions (acidic pH) does not cause any change in the CD signal.  
DF3 is thermodynamically stable in water and at room temperature and pH 7. CD 
spectroscopic studies have shown that the peptide exists in equilibrium between a folded 
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helical dimer and an unfolded monomer. As expected for a monomer–dimer equilibrium, 
its secondary structure is lost in a single transition when chemical denaturation 
(Gdn·HCl) is induced. Further, the Gdn·HCl induced unfolding of DF3 (in the apo and 
metal-bound forms) was found to be reversible; a full recovery of the ellipticity of the 
native state was observed upon suitable dilution of completely unfolded samples. 
 
 
Figure 19: circular dichroism (CD) studies of DF3. a) The far-UV CD spectrum of apo-DF3 in 10 mM 
phosphate buffer at pH 7. b) – d) M(II) titrations [M(II) is Co, Mn, and Zn] following the change in the CD 
signal at 222 nm upon increasing the amount of M(II). The curves were generated from a nonlinear least-
squares fit of the data to a 1:1 binding isotherm. 
 
 
2.1.3.c UV-vis, EPR and Raman studies  
UV–vis spectroscopy was used to obtain more detailed information regarding the 
metal-binding site in DF3. The paramagnetic Co(II) complex (Figure 20) is particularly 
useful in this respect, as the molar extinction coefficient of Co(II) complexes increases as 
the coordination number decreases [10–20 M-1·cm-1 (coordination number 6); 100–150 
M-1·cm-1 (coordination number 5); 400–600 M-1·cm-1 (coordination number 4)]. 
a) b) 
c) d) 
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Figure 20: the visible spectrum of di-Co(II)–DF3 in 50 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), 0.1 M NaCl, pH 7. The concentration of DF3 was 78 µM. The 
extinction coefficient at 548 nm was 98 M-1·cm-1 per Co(II) ion. The spectrum was recorded in a 1 cm path 
length quartz cuvette 
 
DF3 is able to bind Fe(II) ions and to catalyze their oxidation to the ferric state under 
aerobic conditions (ferroxidase activity), forming a stable µ-oxo-di-Fe(III) complex. The 
UV–vis spectrum of the pure di-Fe(III)–DF3 complex exhibits a strong band at λmax = 
350 nm (ε = 5,270 M-1·cm-1), and a moderately intense broad band between 400 and 700 
nm (ε500nm = 1,200 M-1·cm-1) (Figure 21). 
 
 
 
 
 
 
 
 
 
Figure 21:  spectral features of the DF3 di-iron complex in the two oxidation states. The UV-vis 
spectrum of the diferric complex (indicated as Ox) displays the typical oxo-Fe(III) ligand-to-metal charge 
transfer bands from 300 to 350 nm (ε350nm = 5,270 M-1·cm-1). The inset shows the magnified spectrum in 
the visible region. The observed band (ε500nm = 1,200 M-1·cm-1) can be attributed to a phenolate-to-Fe(III) 
charge transfer transition, similarly to DFsc [83-84]. The UV-vis spectrum of the diferrous complex 
(indicated as Rd) was obtained upon reduction of di-Fe(III)-DF3 complex with sodium dithionite. Upon 
exposure to air, complete reformation of the di-Fe(III) species was observed. Repetition of this process 
over several cycles demonstrated the ability of the protein to oscillate between Fe(II)/Fe(III). 
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To better characterize the di-iron center in DF3, we carried out EPR and resonance 
Raman spectroscopic studies. EPR studies showed that di-Fe(III)–DF3 is EPR silent, 
consistent with an antiferromagnetically coupled di-Fe(III) site. The resonance Raman 
spectrum, obtained with laser excitation at 514.5 nm, showed four bands at 1,170, 1,266, 
1,503, and 1,606 cm-1 (Figure 22a). The intensity pattern and frequencies of these bands 
correlate well with the ring deformation modes of a tyrosinate bound to Fe(III), as 
observed in other Fe(III)–tyrosinate proteins and related model complexes [84-89]. 
 
 
Figure 22: resonance Raman spectra (λex = 514.5 nm) of a) di-Fe(III)-DF3 in 100 mM pH 7.0 HEPES 
(0.1 M NaCl, 0.1 M KI), and b) buffer solution alone (100 mM pH 7.0 HEPES, 0.1 M NaCl, 0.1 M KI). 
Drop lines indicate features associated with the buffer and background, while features associated with 
Fe(III)-tyrosinate ring modes are indicated with their Raman shifts in cm-1. 
 
Unfortunately, attempts to observe the Fe–O vibrations (500–600 cm-1) and the Fermi 
doublet (800–900 cm-1) characteristic of Fe(III)–phenolates were unsuccessful. These 
vibrations, however, are often less resonance-enhanced than the ring modes and would be 
difficult to observe owing to the low signal-to-noise ratio in the present resonance Raman 
studies.  
 
2.1.4 Catalytic activity 
The goal of the current work was to introduce a phenol-binding site into DF1, 
converting it into a phenol oxidase, similar to the natural enzymes alternative oxidase 
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(AOX) and plastid terminal oxidase (PTOX). These catalysts cycle between di-Fe(II) and 
di-Fe(III) states as they reduce O2 and then use the oxidizing equivalents to convert 
quinols to quinones [81-82] (Figure 23).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: proposed catalytic cycle for alternative oxidase. The resting diferric state is reduced by 
quinol to yield quinone. In the next step the diferrous state reduces O2, to form a peroxo-diferric 
intermediate. Finally, the two oxidating equivalents of this intermediate are used to convert the second 
quinol, thus affording the diferric resting state of the protein.  
 
A successfully designed phenol oxidase should:  
(i) position the di-Fe(II) cofactor for facile oxidation with O2;  
(ii) stabilize the resulting di-Fe(III) cofactor, which otherwise would be highly insoluble 
in aqueous solution;  
(iii) bind phenols to allow two-electron oxidation of the substrate and regeneration of the 
diferrous cofactor;  
(iv) allow product release with entry to a new catalytic cycle;  
(v) minimize one-electron radical-forming processes that would give rise to Fenton 
chemistry or destruction of the catalyst.  
Addition of two equivalents of Fe(II) to DF3 in the presence of ambient oxygen led to 
rapid formation of a di-Fe(III) species with an absorbance spectrum characteristic of an 
oxo-bridged diferric cofactor (ε350nm = 5,270 M−1·cm−1 per di-iron site) [90]. 
Spectroscopic titrations indicated that dithionite reduction and air oxidation of the 
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cofactor are reversible over several cycles (see Figure 21). Having established the ability 
of diferric DF3 to undergo reversible two-electron reduction/oxidation cycles, we 
evaluated its ability to catalyze the oxidation different substrates, such as 3,5-DTBC, 4-
AP, PPD and OPD. Catalytic activity investigated with the DFtet series of proteins was 
taken as reference [62]. The kinetic results are summarized in Table 4. 
 
Table 4. Kinetics parameters obtained for the oxidation of the different substrates 
Protein Substrate Km (mM) kcat (min-1) kcat/Km (M-1·min-1) 
3,5-DTBC a 2.09 ± 0.31 13.20 ± 1.21 6,315 
4-AP b 1.97 ± 0.27   2.72 ± 0.19 1,380 
PPD c 8.87 ± 2.58   0.73 ± 0.03 83 di-Fe(III)-DF3 
OPD d Not detected 
G4-DFtet 4-AP b 0.83 ± 0.06   1.30 ± 0.10 1,540 
 
a
 3,5-di-tert-butylcathecol; b 4-aminophenol; c p-phenylendiamine; d o-phenylendiamine 
All experiments were performed in 100 mM HEPES/100 mM NaCl buffer (pH 7.0). 
 
 
2.2 Discussion 
The DF3 design was based on DF1 scaffold. Its sequence was first modified by 
introducing four Gly residues in both positions 9 and 13 of each α2 monomer, in order to 
increase the active site cavity and create a binding site for organic cofactors, according to 
earlier studies on DF tetrameric models [60-62]. Further, we redesigned the loop 
sequence, in order to optimize its conformation.  
In DF1, the loop sequence Val-Lys-Leu was designed to idealize a γ-αL-β loop, a 
common inter-helical linker in proteins [91-92]. A careful examination of the loop region 
in the crystal and solution structures of DF1 and several variants revealed that the overall 
structural context was not optimal. A Rose-like αL-β conformation was observed in only 
about one third of the structures; in the remaining structures, the loop residues adopted 
alternative conformations [57]. Thus, the designed conformation of the loop did not 
appear to be as stable as expected, and could be differently shaped, depending on the 
crystal environment [56, 59]. 
In the subsequent analogue DF2 [54], the former loop sequence Val-Lys-Leu was 
replaced by Val-Gly-Asp, according to results emerged from earlier studies on α-
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α hairpin sequence pattern [91-92]. The γ position is most often occupied by hydrophobic 
residues, the αL position is predominantly stabilized by Gly or hydrophilic residue with 
flexible side chain and the β position is occupied by hydrophilic or small residues. 
Although these mutations improved some DF2 properties, respect to DF1, the loop was 
still flexible, as revealed by the structural characterization both in the solid state [57] and 
in solution [55]. The di-Cd(II) complex showed in the crystal structure a ‘‘Rose-like’’ αL-
β inter-helical turn [93]; however, the relatively high B-factor values of the loop residues 
indicated some flexibility [57]. This finding was confirmed by the NMR structure of di-
Zn(II) complex, which unexpectedly showed in solution two conformational families of 
the loop region [55].  
In order to further stabilize the desired “Rose-like’’ αL-β  inter-helical turn, we 
introduced in DF3 the sequence Thr-His-Asn, as suggested by the statistical analysis of 
the structures and sequence preferences of inter-helical hairpin [57]. 
Histidine was included to stabilize an αL conformation, which was necessary for a Rose 
motif. This residue occupies in the loop a Ccap position. Although glycine is a good 
helix-terminating amino acid for its intrinsic flexibility, histidine is also highly favoured 
at this position: its positive dihedral angles allow a sharp turn in the peptide backbone 
and prevent helix propagation [94]. Asparagine, located near the N-terminus of the 
second helix, was selected as N-capping residue [95-96]. 
The new DF3 protein showed improved solubility. In particular apo-DF3 proved to be 
extremely soluble in water (up to 3 mM), compared with other DF members (10 µM, 
DF1; 0.5 mM, DF2). This feature represents a significant improvement in the properties 
of the DF family of artificial di-iron proteins. For DF1 and DF2 members in the apo state, 
addition of organic solvents, such as dimethyl sulfoxide and acetonitrile, was often 
required to obtain aqueous solutions at millimolar concentrations. These coordinating 
solvents should be avoided because they may bind to the di-metal site and affect its 
potential functionality. Indeed, in the X-ray structure of di-Mn–L13A-DF1 a bridging 
dimethyl sulfoxide molecule, derived from the crystallization buffer, was found in the 
metal site [59]. Thus, it is desirable to use water as the sole solvent. The remarkably high 
water solubility of DF3 allowed us to perform all the studies described in this work in 
aqueous solutions. 
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The NMR solution structure of di-Zn(II)-DF3 was determined using a strategy similar to 
that reported for previous dimeric DF proteins [53,55,57]. Previous studies of dimeric 
DF1 and DF2 proteins indicate the di-Zn(II) substitution reproduces the structural 
properties of the di-Fe(II) and di-Mn(II) forms of the protein, having minimal effect on 
the tertiary structure or ligation geometry [9, 52]. 
The well-dispersed resonances are indicative of a well-defined structure. In particular, the 
presence of several resonances shifted in the region -0.5 - 1.0 ppm is typically caused by 
the persistent interaction of aliphatic side chains with aromatic rings expected for a well-
folded protein. The elements of secondary structure along di-Zn(II)-DF3 were first 
delineated using information provided by NOE data and CαH conformational shifts 
(Figure 24).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24: spectral data used for secondary structure determination for di-Zn(II)-DF3. a) NOE 
connectivities are indicated by a line drawn between two residues, and are classified as strong (    ), 
medium (   ) and weak (   ). Distinctive intensities of NOEs due to sequential and medium-range (i.e. 
residues less than 5 apart) contacts were used to define the elements of secondary structure in the protein. 
b) Chemical shift index (CSI) of α protons.  
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Two stretches of strong sequential dNN(i,i+1) NOEs, weak or absent dαN(i,i+1), NOEs, 
medium-range dαN(i,i+3), dαN(i,i+4), and dαβ(i,i+3) NOEs, and large upfield conformational 
shifts indicate the presence of two α-helices spanning approximately residues 2-24 and 
27-47. The secondary chemical shifts of the CαH protons [97] show two stretches of 
negative values, characteristic of α-helical structures, in the regions encompassing the 
residues 1-24 and 27-47. The good correlation between all the experimental data allowed 
to define two stable helical segments for di-Zn(II)-DF3 in solution: helix 1 (residues 2-
24), and helix 2 (residues 27-47). The experimental data were also in agreement with the 
helix lengths determined from the φ and ψ angles of the final calculated structures. Direct 
indication about the tertiary fold could be obtained from the unambiguous assignment of 
long-range (> i, i+4) NOE connectivities, using the well-resolved resonances of aromatic 
rings and methyl groups, as structural probes.  
A family of structures was calculated using CYANA [98], with the di-Zn(II) site treated 
essentially the same as in the DF2 and DF2t structures [55, 57]. The 40 CYANA 
structures, with the lowest target function, were then subjected to further refinement by 
restrained energy minimization (REM). A final ensemble of 30 refined structures was 
selected to represent the di-Zn(II)-DF3 solution structure (Figure 17f). This family of 
structures does not have a distance constraint violation larger than 0.5 Å (Table 5).  
The overall stereochemical quality of the set of structures indicates that di-Zn(II)-DF3 
structure is comparable to that of a 1.0 Å well-defined X-ray structure [99]. The solution 
structures of di-Zn(II)-DF3 clearly confirm all the aspects of the intended design. Despite 
the addition of four helix-destabilizing Gly residues, the protein retained the ability to 
fold correctly. 
The di-Zn(II)-DF3 tertiary fold consists of an antiparallel four-helix bundle with an up-
down-up-down topology. In the structure, helix 1 and helix 2 pack in an antiparallel 
manner against their symmetry related helix 1’ and helix 2’, respectively. As in native 
proteins, the apolar side chains are located in the core of the structure. The packing 
pattern of DF3 hydrophobic core spans the whole helices length. Most of the core 
residues in the protein adopt well-defined side chain conformation, with χ1 angle values 
close to those intended in the design. 
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Table 5. NMR and refinement statistics the 30 final NMR structures 
 
 di-Zn(II)-DF3  
NMR distance and dihedral constraints  
Distance constraints  
    Total NOE 1,402 
    Intra-residue 460 
    Inter-residue 942 
      Sequential (|i – j| = 1) 370 
      Medium-range (|i – j| < 4) 304 
      Long-range (|i – j| > 5) 94 
      Intermonomer 174 
  
Structure statistics  
Violations (mean and s.d.)  
    Distance constraints (Å)      
        0.1 < d ≤ 0.2 36.07 ± 4.35 
        0.2 < d ≤ 0.3 2.43 ± 1.36 
        0.3 < d ≤ 0.4 0.07 ± 0.25 
        0.4 < d ≤ 0.5 0.03 ± 0.18 
    Max. distance constraint violation (Å)  0.25 ± 0.05 
Deviations from idealized geometry*  
    Bond lengths (Å)     0.013 
    Bond angles (º) 2.1 
    Close contact 0 
Average pairwise r.m.s. deviation** (Å)     
 
    Heavy      1.39 ± 0.16 
    Backbone (2-46) 0.68 ± 0.12 
   
* From the PDB validation software; **Pairwise r.m.s. deviation was calculated 
among the best 30 energy minimized conformers after superposition for the best 
fit of the atoms of the residues indicated in parentheses.  
 
The helices within each monomer span residues 2-24 and 27-47, as defined by the pattern 
of hydrogen bonding as well as by the backbone torsion angles φ and ψ. As is often 
observed in the NMR structures of natural proteins, the ends of the helices show slightly 
greater distortion from ideal helical geometry than the remaining residues.  
The loop region, comprising residues 24-26, is well defined and it is characterized, in all 
30 selected structures, by an αRαLβ conformation. Thr24 adopts an αR-conformation (φ= -
112 ± 24°; ψ = -29 ± 6°); His25 adopts an αL-conformation (φ= 43 ± 6°; ψ= 36 ± 12°); 
Asn26 is in a β-conformation (φ = -103 ± 19°; ψ = 149 ± 5°), consistent with its main-
chain chemical shift index (Figure 24). The pattern of hydrogen bonding (Figure 17d) 
and dihedral angle values of the loop residues are typical for a “Rose-like” αL-β inter-
helical turn [93]. 
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Interestingly, the NH group of His25 is involved in the C-capping motif [93,100-101]: the 
amide proton is hydrogen bonded to the Leu21 carbonyl group. The C-capping motif is 
further stabilized by two additional H-bonds: the first involves the Nε proton of His25 
imidazole ring and the amide proton of Glu22, the second involves the Thr24 amide proton 
and the carbonyl group of Ala20. Asn26 adopts a β-conformation and is well situated to 
make N-cap interaction with the N-terminus of the helix 2 [95-96]. In all selected 
structures, the Asn26 backbone carbonyl group forms an hydrogen bond to the amide 
proton of Leu29, three amino acids toward the C-terminus. The average COi ← NHi+3 
hydrogen bond distance is 2.83 ± 0.19 Å. The hydrophilic side chain of Asn26 is solvent 
exposed and, in about 50% of selected structures, it forms a well-directed hydrogen bond 
with the carbonyl oxygen of Thr24. Thus, the selected loop sequence encompasses all the 
requirements for stabilizing the desired Rose motif. As a consequence, aggregation 
phenomena are inhibited, and the solubility in water solution is highly improved (> 2 
mM). The increased solubility also benefits from the polar nature of the loop: indeed, the 
side chain of the C-cap (His25) residue, as well as the carbonyl oxygens of C1 (Thr24) and 
C-cap are solvent exposed.  
This hydrogen bond network, which stabilizes the DF3 inter-helical turn, was not 
observed in DF1, since the DF1 loop lacks a proper residue able to assume an αL 
conformation, as well as an N-capping residue at the β-position [52]. The metal-binding 
site in di-Zn(II)-DF3 is stabilized by second-shell hydrogen bonds (Figure 25 and Figure 
11), as already observed in previous structures of the dimeric DF proteins [9].  
In all selected structures the primary ligand Glu10 accepts second-shell hydrogen bonds 
from Tyr17' of a neighbouring monomer. The average distance between the tyrosine 
phenolic oxygen and the glutamate carboxylate oxygen (3.09 ± 0.28 Å) and the geometry 
are consistent with the formation of a hydrogen bond. Similarly, Asp35 accepts a second-
shell hydrogen-bonded interaction from the primary ligand His39'. The average distance 
between the between the carboxylate oxygen of Asp35 and the Hε2 proton of His39' is 2.97 
± 0.12 Å. This distance is indicative of a reasonably strong hydrogen bond, possibly 
imparting partial imidazolate character to the histidine side chain [102-104], and it is in 
good agreement with the NMR data (His39 Hε2 chemical shift) [105]. 
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Figure 25: details of the di-Zn(II) site in DF3. First coordination shell residues are depicted as sticks; the 
purple spheres indicate the metal ions. 
 
CD  titration experiments demonstrated that the binding of metal ions to apo-DF3 
followed in all cases a 1:1 stoichiometry, with one metal ion binding one DF3 monomer 
(two ions per DF3 dimer) (Figure 19b–d). The dissociation constants (Kdiss) for divalent 
metal ion binding were calculated at pH 7 from the titration data using a 1:1 (metal ion to 
monomer) binding model. Nonlinear least squares analysis gave values in the micromolar 
range [0.24 ± 0.02 µM for Co(II), 0.23 ± 0.04 µM for Mn(II), and 0.11 ± 0.01 µM for 
Zn(II)], and in agreement with the Irving–Williams series [106]. A comparison with 
previous metal-binding data for DF proteins and bacterioferritin indicates similar overall 
binding affinities, with DF3 showing the lowest metal selectivity among the other DFs 
(Table 6).  
Table 6. pKmet for dinuclear metalloproteins 
 Bacterioferritin a DF2 b DFsc c DF2t d DF3 e 
Zn(II) 7.0 6.7 7.0 6.6 7.0 
Co(II) 6.0 4.8 3.8 5.0 6.6 
Mn(II) - 4.1 4.1 5.1 6.6 
 
a data from ref. [107]; b data from ref. [54]; c data from ref. [108]; d data from ref. [55]; e data from ref. [11] 
 
In particular, DF3 has a comparable affinity for Zn(II), with respect to other DFs and 
bacterioferritin, whereas the affinities of DF3 for Mn(II) and Co(II) are the highest 
among all the DF proteins. This result may be ascribed to a more flexible metal-binding 
site in DF3. From a coordination geometry point of view, Zn(II) is well documented to 
strongly prefer to bind protein ligands in a tetrahedral geometry, whereas Co(II) and 
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Mn(II) prefer to bind in higher coordination number geometries, such as octahedral and 
trigonal bipyramidal [109]. For example, an analysis of crystal structures of 
metalloproteins present in the PDB, with resolutions of 1.6 Å or lower, revealed that 
coordination numbers equal to or higher than 5 represent only 25% of all the 
crystallographically characterized Zn(II) metalloproteins [110]. In the case of Fe(II/III)- 
and Mn(II)-containing proteins, 88 and 100% of them have coordination numbers equal 
to or higher than 5, respectively [110]. Furthermore, on the basis of hard and soft 
acid/base theory, the DF proteins should prefer coordination with hard Lewis acids such 
as Mn(II) and Fe(III), owing to the high number of carboxylate oxygen donors (hard 
Lewis bases) present in the metal-binding site [111]. All the DF proteins synthesized to 
date, however, have been shown to have higher affinity for Zn(II), a softer Lewis acid 
(Table 6). Thus, since the nature of the coordinating amino acid residues at the metal site 
in DF3 is the same as in previous DF proteins, the higher affinity of DF3 for binding 
Mn(II) and Co(II) could be the result of a more structurally flexible metal-binding site 
that imposes fewer geometric restrictions on the metal ions. As a consequence, metals 
that prefer coordination numbers equal to or higher than 5, such as Mn(II), Co(II), and 
Fe(II/III), would be favored to bind DF3. 
The free energies of dimerization of the DF3 proteins were determined by globally fitting 
the baseline and thermodynamic parameters to an equilibrium between folded dimers and 
unfolded monomers [53]. Thus, the apparent free energy of dimerization extrapolated to 
zero denaturant concentration ∆GuH2O of apo-DF3 was calculated to be 8.1 ± 0.3 kcal·mol-
1
 (33.9 kJ·mol-1) at pH 7. The presence of divalent metals significantly increases the 
thermodynamic stability of DF3 at pH 7 (Table 7, Figure 26). The folded form of DF3 
was stabilized by 10.4 kcal·mol-1 (43.5 kJ·mol-1) in the case of Zn(II), and only by 2.3 
and 2.9 kcal·mol-1  (9.6 and 12.1 kJ·mol-1) for Co(II) and Mn(II), respectively.  
 
Table 7. Thermodynamic parameters derived from the fit of the guanidine hydrochloride induced 
unfolding curves for apo-DF3 and di-M(II)–DF3 (M is Co, Mn, Zn) at pH 7 (1 kcal = 4.184 kJ) 
Protein ∆GuH2O (kcal·mol-1)a [Gdn·HCl]1/2 (M) m (kcal·mol-1 M-1) 
apo-DF3   8.1 ± 0.3 1.48 1.4 ± 0.1 
di-Co(II)-DF3 10.4 ± 0.3 2.11 1.8 ± 0.1 
di-Mn(II)-DF3 11.0 ± 0.6 2.01 2.2 ± 0.2 
di-Zn(II)-DF3 18.5 ± 1.3 3.15 3.7 ± 0.4 
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Figure 26: the effect of metals on the thermodynamic stability of DF3. Guanidine hydrochloride 
(Gdn·HCl) denaturation curves of apo-DF3 + 1 mM EDTA (circles), apo-DF3 + 1 mM Co(II) (squares), 
apo-DF3 + 1 mM Mn(II) (triangles), and apo-DF3 + 1 mM Zn(II) (diamonds). [θ]222 was monitored as a 
function of the concentration of added denaturant in 10 mM phosphate buffer and 0.1 M NaCl (pH 7). The 
smooth curves were generated by globally fitting the free energy of dimerization ∆GuH2O in the absence of 
Gdn·HCl, m (δ ∆GuH2O / δ [Gdn·HCl]), and the baseline parameters to the data as described in [53]. 
 
The extent of thermodynamic stabilization agrees well with the strength of metal binding 
(Zn[Mn & Co), as previously discussed. The m values derived from the denaturation 
curve fitting also increase with the strength of metal binding (Table 7). 
The m value is typically interpreted as being proportional to the difference in solvent-
accessible surface area between the unfolded and the folded state of a protein [112]. 
Consequently, in di-Zn(II)–DF3 the maximum decrease of solvent-accessible surface 
area is observed upon folding. Hence, the observed increase of the m value when divalent 
ions are present could be related to an increase in the compactness of the four-helix 
bundle due to strong metal ion binding. 
The initial design of DF proteins focused on the construction of a thermodynamically 
stable framework, able to bind the di-metal cofactor, and to react with molecular oxygen 
[52]. In subsequent studies, the basic framework was re-engineered, with the aim of 
expanding the active site pocket, to allow binding of organic substrates [9, 49, 54, 56]. 
Although the first two objectives were achieved, the expansion of the active site - with 
concomitant loss of packing and dehydration of apolar side chains - proved to be 
unfeasible within the initially designed sequence.  When the active site cavity was 
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expanded, the desired fold became energetically unfavorable, leading to either unfolded 
protein or off-pathway formation of misfolded aggregated species [53].  We successfully 
increased the stability and conformational specificity of the protein through the redesign 
of a loop quite distant from the active site. In fact, the destabilization caused by 
introducing four Gly residues into the core structure of DF3 dimer was compensated by 
the increased stability of the inter-helical loop. Thus, the loop had a profound influence 
on the solubility (> 2 mM), stability, and ultimately on the possibility to introduce 
destabilizing mutations into the active site.  
We compared the thermodynamics of folding of apo-DF3 with the apo forms of DF1 and 
L13G-DF1, as assessed by chemical denaturation in the absence of metal ions at pH 5.5 
[53]. Folding and dimerization are thermodynamically linked for this series of peptides, 
and the experimentally observed values for association/folding are ∆GuH2O are 23.5 ± 0.3 
kcal·mol-1, 12.7 ± 0.3 kcal·mol-1 and 10.3 ± 0.6 kcal·mol-1 for apo-DF1, apo-L13G-DF1 
and DF3, respectively (corresponding to approximately 0.01 fM, 0.6 nM, and 0.03 µM). 
The Leu residues at positions 9 and 13 are almost completely inaccessible to solvent, and 
hence considerably influence the stability of the three proteins. In apo-DF1 replacement 
of Leu13 with Gly is quite deleterious, (∆∆G = 11 kcal·mol-1), reflecting both the decrease 
in the helix propensity (approximately 2 kcal·mol-1dimer [113-114]) as well as the 
decreased contribution from burial of Leu13.  It is therefore not surprising that the double 
replacement of Leu13 and Leu9 with Gly within the DF1 framework was problematic.  
The introduction of Gly at both 9 and 13 was, however, feasible in DF3; the value of 
∆∆G for DF3 vs. L13G-DF1 is 2 kcal·mol-1. In this case ∆∆G reflects the destabilizing 
effects associated with the L9G substitution as well as the stabilizing effects of the 
improved loop; in balance the effect is far less drastic than that observed for L13G in 
DF1.  
The shape, position, and intensity of the absorption bands in the visible spectrum of 
di-Co(II)–DF3 suggest that the metal ions are in a pentacoordinated geometry [115], as 
intended in the design (Figure 20, Table 8). Furthermore, the spectrum is remarkably 
similar to the spectra of previous di-Co(II)–DF proteins [52, 54, 60, 116], and to the 
spectrum of di-Co(II)–bacterioferritin, which contains an identical 4-Glu, 2-His binding 
site (Table 8) [108, 117]. However, di-Co(II)–DF3 exhibits lower molar extinction 
coefficients per Co(II) ion compared with the other di-Co(II) proteins discussed here. 
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This may represent a tendency for the metal site to adopt a less strained geometry. Thus, 
the binding stoichiometry and the coordinating environment of the active site are both 
consistent with the intended design of DF3 and with the crystal structures of di-Zn(II)–
DF1 (PDB code 1EC5) [52], di-Zn(II)–DF2t (PDB code 1MFT) [57], and di-Co(II)–DF1-
L13A (PDB codes 1OVU and 1OVV) [56]. 
 
Table 8. Spectroscopic data for Co(II) substituted DF derivatives, compared to Co(II)-
bacterioferritin 
Protein λ (nm) ε (M-1·cm-1) a λ (nm) ε (M-1·cm-1) a λ (nm) ε (M-1·cm-1) a 
DF1 b 524 143 574 190 594 165 
DF2 c 520 140 550 155 600 90 
DFtet d 520 125 550 140 597 80 
DFsc e 529 124 550 136 600 86 
DF3 f 522 88 548 98 598 66 
Bacterioferritin g 520 126 555 155 600 107 
 
a per Co(II) ion; b data from ref. [61]; c data from ref. [54]; d data from ref. [60]; e data from ref. [108]; f data 
from ref. [11]; g data from ref. [117].  
 
The UV–vis spectrum of the pure di-Fe(III)–DF3 (Figure 21) is consistent with an 
oxo-to-Fe(III) charge transfer transition in a µ-oxo-di-Fe(III) unit. Proteins and model 
complexes containing oxo-bridged di-iron clusters typically exhibit intense absorption 
bands in the UV region (λmax = 300–370 nm, ε = 4,000–9,000 M-1·cm-1 per di-iron site) 
[118-123].  
Furthermore, similar ligand-to-metal charge transfer (LMCT) bands were described in 
previous studies with di-Fe(III)–DF proteins [54, 59, 62]. The assignment has recently 
been confirmed for di-Fe(III)–DF2t, as the µ-oxo-di-Fe(III) unit was structurally 
characterized by X-ray crystallography [124]. The moderately intense broad band 
between 400 and 700 nm was assigned to a O(ppi) → Fe(dpi*) tyrosinate-to-Fe(III) 
LMCT transition [125-126], on the basis of resonance Raman data (vide infra), as well as 
on its similarity with well-characterized iron proteins and small-molecule model 
complexes with phenolate/tyrosinate–Fe(III) interactions. Examples include the iron 
carrier transferrins (λmax = 464 nm; ε = 2,500 M-1·cm-1) [125, 127-128], protocatechuate-
3,4-dioxygenase (λmax = 450 nm; ε = 2,600 M-1·cm-1) [129-131], and mammalian 
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binuclear purple acid phosphatases (λmax = 510 nm; ε = 4,000 M-1·cm-1) [132-135]. The 
position and the intensity of the LMCT transitions in both tyrosinate–iron enzymes and 
model complexes have been shown to depend on the ligand environment [136-140]. In 
particular, the molar extinction coefficient depends on the number of phenolate groups 
coordinated to the metal, with each phenolate bound to the Fe(III) ion contributing 
approximately 1,000– 2,000 M-1·cm-1 to the intensity of the absorption [141]. 
Mammalian binuclear purple acid phosphatase, with only one tyrosinate ligand bound to 
the Fe(III) site, represents an interesting and as yet unexplained exception to this 
relationship [142]. On the basis of these data, the extinction coefficient at 500 nm for di-
Fe(III)–DF3 is consistent with the coordination of one Tyr residue to the Fe(III) ion. 
Recently, the coordination of a Tyr residue to a di-Fe(III) center has been 
spectroscopically characterized in two variants of the monomeric single-chain derivative 
of DF, namely, DFsc and DFscE11D [83-84]. A combination of resonance Raman, near-
IR CD, magnetic CD, variable temperature, variable-field magnetic CD, and X-ray 
absorption spectroscopies was needed to fully characterize the di-Fe(II) and di-Fe(III) 
sites [83-84]. On the basis of our experimental data and in analogy with this recent 
spectroscopic characterization, we can assign the 500-nm chromophore to a tyrosinate-to-
Fe(III) LMCT transition. We suggest that the reaction of DF3 with Fe(II) ions under 
aerobic conditions results in the formation of a µ-oxo-di-Fe(III) unit with one Tyr residue 
coordinated to the dimetal site (Figure 27). 
 
Figure 27: schematic representation of the proposed coordination site of di-Fe(III)-DF3. One Tyr 
 residue (either 17 or 17’) may coordinate the Fe(III) ion. 
The amino acid sequence of DF3 contains two Tyr residues (Tyr17/Tyr17’), which were 
intended in the design to form strong second-shell hydrogen bonds with the primary Glu 
10’/Glu10 ligands of the neighboring monomer. The structural characterization of di-
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Zn(II)–DF3 [10], as well as of previously characterized DF proteins [52, 55, 56, 58, 59, 
124], showed that these two Tyr residues are in close proximity of the dimetal site. Thus, 
one Tyr could terminally coordinate to the di-iron center, as already observed for di-
Fe(III)–DFsc [83-84]. We have recently obtained di- Fe(III)–DF3 crystals suitable for X-
ray diffraction analysis. These studies will allow us to definitively characterize the di-
Fe(III) site in DF3. 
The substitution of Leu at positions 9 and 13 (which blocked access to the active site) 
with the small Gly residue was effective in improving the active-site access. The first 
experimental evidence of this finding was that different M(II) ions were able to 
spontaneously enter into the hydrophobic core of the folded apo-DF3 dimer and 
coordinate to the binding site. This observation is remarkably different from that for DF1, 
which had to be denatured first and then refolded in the presence of metals to form the 
desired dimetal complexes. In addition, the diferric form of DF3 shows enhanced 
accessibility to the metal site compared with previous di-Fe(III)–DF complexes. Addition 
of azide to a solution of di-Fe(III)–DF3 results in the immediate appearance of two 
intense charge transfer bands at λmax = 346 nm (ε346 = 1.20 · 104 M-1·cm-1) and λmax = 460 
nm (ε460 = 7.70 · 103 M-1·cm-1), characteristic of N3¯ -to-Fe(III) transitions (Figure 28).  
 
Figure 28: titration of di-Fe(III)-DF3 (78 µM) with NaN3 in 50 mM HEPES, 0.1 M NaCl, pH 7 in a 1 
cm path-length quartz cuvette. UV-vis spectrum of di-Fe(III)-DF3 upon addition of increasing amounts 
of NaN3. The inset shows the increase in absorbance at 460 nm as a function of ligand concentration. The 
curve was obtained from a fit of the data to the Hill’s equation. 
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The spectrum of N3¯ -bound di-Fe(III)–DF3 is almost identical to that of the N3¯ -bound 
di-Fe(III)–stearoyl-ACP ∆9-desaturase complex (λmax of 345 and 456 nm, extinction 
coefficients not reported) and to that of the previously characterized azido-di-Fe(III)–
DF2 spectrum (λmax = 340 nm, ε340 = 1.28 · 104 M-1 cm-1; λmax = 460 nm, ε460 = 8.70 · 103 
M-1·cm-1) [59, 143]. In addition, the spectrum also resembles that of the 
azidomethemerythrin complex (λmax = 326 nm, ε326 = 6.75 · 103 M-1·cm-1; λmax = 446 nm, 
ε446 = 3.70 · 103 M-1·cm-1) [83, 144]. The extinction coefficients of the azide complex of 
di-Fe(III)–DF3 are approximately 2 times greater than those of azidomethemerythrin, 
which is known to bind just one azide anion per di-iron site in a nonbridging mode [145-
146]. The small differences in the positions of the absorption bands can be related to the 
first coordination sphere of the metal ions. Figure 29 compares the active-site structures 
of hemerythrin (Figure29a), stearoyl-ACP ∆9-desaturase (Figure29b), and the DF 
proteins (Figure29c). A titration of di-Fe(III)-DF3 with sodium azide (Figure 28, inset) 
allowed us to obtain a binding curve that was fitted to the Hill equation ([NaN3]N/(K + 
[NaN3]N) [147].  
 
Figure 29: comparison of the active site structure in different di-iron proteins and model compounds, 
as derived from X-ray crystallography. a) Deoxy-hemerythrin (PDB code 1HMD) [148]; b) stearoyl-
ACP ∆ 9-desaturase (PDB code 1AFR) [149]; c) L13G-DF1 (PDB code 1LT1) [58]. 
 
 
Comparison of the values obtained from the fit (N = 2.04 ± 0.15, K = 0.20 ± 0.02 M, 
and R = 0.99) with those obtained previously for di-Fe(III)–DF2 (N = 1.5 ± 0.1, K = 0.56 
M, and R = 0.99) demonstrates that the accessibility to the di-iron site of exogenous 
molecules has been greatly improved in di-Fe(III)–DF3. The accessibility enhancement 
could be quantified to be close to 150%, as the K values indicate. In addition, the Hill 
a) b) c) 
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coefficient (N) and the high extinction coefficient of the azido-to-Fe(III) absorption bands 
suggest that two azide molecules may bind to the di-Fe(III) site of DF3.  
These results are in agreement with the previous suggestion of an accessible and 
coordinatively flexible metal-binding site in di-Fe(III)–DF3, which is capable of 
accommodating small molecules. Thus, kinetic investigations were conducted using 
different substrates. Initial velocities were extracted from the steady-state portion of the 
progress curves (first 30 s after addition of the substrate). Kinetic parameters (vmax, Km 
and kcat) were obtained assuming a Michaelis-Menten model and determined from a 
Lineweaver-Burk plot (Figure 30). 
For 4-AP oxidation, the protein followed Michaelis-Menten kinetics with values of 1.97 
± 0.27 mM and 2.72 ± 0.19 min−1, respectively, for Km and kcat (Table 4, kcat/Km = 1,380 
M−1 min−1). Measurement of the reaction over the course of an hour indicated that the 
protein was capable of at least 50 turnovers. Kinetic investigations using other di-amine 
and ortho-quinol substrates were consistent with the anticipated catalytic properties of di-
Fe(III)-DF3.  
The active site cleft in the model of DF3 could also accommodate the widely studied 
substrate 3,5-ditert-butyl-catechol (3,5-DTBC) [150]. Indeed, di-Fe(III)-DF3 catalyzed 
the oxidation of this catechol derivative to the corresponding quinone (3,5-DTBQ) 
(Figure 30b), with a fivefold greater value of kcat/Km than that for 4-AP (Figure 30a), 
reflecting an increase in kcat (Table 4). Amino-aniline substrates were expected to bind 
more weakly to the diferric center [151]. Indeed, kcat/Km for the two-electron oxidation of 
para-phenylenediamine (Figure 30c) was 75-fold lower than the value for 3,5-DTBC, 
and no catalysis was observed for ortho-phenylenediamine.  
 
Chapter 2 - De novo design of a di-iron catalytic model: DF3  
 
 
 - 55 - 
 
Figure 30: catalytic activity of di-Fe(III)-DF3. Initial rate of the oxidation versus substrate  concentration 
for a) 4-AP, b) 3,5-DTBC, c) PPD. Di-Fe(III)-DF3 concentration was 2µM in a) and c) and 13µM in b). 
Kinetic parameters (Kcat and Km) were determined from the Lineweaver Burk analysis (see insets). The 
analyzed substrates undergo a similar oxidation reaction, since they bear in their molecular structures two 
ortho- or para- related electron supplying groups (-OH or –NH2), giving rise to the corresponding 
benzoquinone monoimines, quinones and di-imines, respectively. 
 
 
The de novo design of a catalytically active di-iron protein illustrates a well-known 
concept in natural proteins: “Protein function and stability are often the result of opposite 
a) 
b) 
c) 
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requirements”. This trade-off between conformational stability and function is 
particularly apparent in metalloproteins, which reflect a delicate interplay between 
opposing requirements for binding (favoring static, coordinately saturated geometries) 
versus function (often requiring coordinately unsaturated and sometimes unusual 
geometries). The requirement of forming a cavity to bind phenol provided yet another 
restraint opposing stability. Analysis of the thermodynamic stability of a series of DF1 
mutants versus DF3 [10] reinforced the concept that the functional mutations were indeed 
thermodynamically destabilizing and that the improved turn-forming sequence helped 
improve the overall stability in the face of these mutations.  
 
 
2.3 Experimental section 
Reagents were obtained from commercial suppliers and used as received. All amino 
acids, the Sieber resin, O-7-Azabenzotriazol-1-yl-N,N,N’,N’’-tetramethyluronium 
hexafluorophosphate (HATU), hydroxybenzotriazole (HOBt) and Benzotriazol-1-yl-oxy-
tripyrrolidinophosphonium hexafluorophosphate (PyBOP) were purchased from Nova 
Biochem; piperidine, and scavengers were from Fluka. DIEA and TFA were from 
Applied Biosystems. All solvents used in the peptide synthesis and purification were 
anhydrous and HPLC grade respectively, and were supplied by Romil. The substrates 
used in the catalytic assays (4-AP, 3,5-DTBC , PPD, and OPD) were purchased from 
Sigma-Aldrich and were used without further purification. 3,5-DTBQ, H2O2 (30%, v/v) 
and all the standard chemicals were obtained from Fluka. The structures were generated 
with Visual Molecular Dynamics (VMD;  http://www.ks.uiuc.edu/Research/vmd/). 
 
2.3.1 Synthesis and purification 
DF3 was chemically synthesized by automated solid-phase synthesis using an ABI 
433A peptide synthesizer (Applied Biosystems, Foster City, CA, USA). The N- and C-
termini were acetylated and amidated, respectively. The instrumental software Fmoc 
protocols were modified to provide an improved synthetic outcome. PyBOP/ HOBt 
activation was used instead of the instrumental HATU activation. The synthesis was 
carried out on a 0.1-mmol scale using PALPEG- PS resin from Applied Biosystems 
(substitution level 0.22 mmol · g-1).  
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The crude product (416 mg) was analyzed to homogeneity by analytical reverse-
phase high-performance liquid chromatography (RP-HPLC), performed with a Shimadzu 
LC-10ADvp equipped with an SPDM10Avp diode-array detector. A Vydac C18 column 
(4.6 mm · 150 mm; 5 µm), eluted with an H2O/0.1% trifluoroacetic acid (TFA) (solvent 
A) and CH3CN/0.1% TFA (solvent B) linear gradient, from 10 to 80% (solvent B) over 
35 min, at 1 mL·min-1 flowrate, was used in all analyses. Purification was accomplished 
by preparative RP-HPLC (22 mm · 250 mm; 10 µm) Vydac C18 column, at a flow rate of 
22 mL·min-1, with a gradient of acetonitrile in 0.1% aqueous TFA, from 10 to 80% over 
58.1 min. Pure DF3 was obtained in 18% yield from the crude product and its purity was 
ascertained by analytical RP-HPLC and matrix-assisted laser desorption ionization time 
of flight mass spectrometry. 
 
2.3.2 Structural and physico-chemical characterization 
2.3.2.a NMR data collection and analysis 
Samples for NMR spectroscopy were prepared using the following conditions: to a 
0.25 mM DF3 solution in phosphate buffer (50 mM, in 90% H2O/10% D2O, pH 6.0) were 
added dropwise 24 µl of a ZnCl2 aqueous solution (0.14 mM, 10 % fold excess); 3-
(trimethylsilyl) propionic-2,2,3,3-D4 acid sodium salt (TSP) was added as internal 
reference.  All NMR spectra were acquired at 25 °C on a Bruker Avance 600 
spectrometer equipped with a triple resonance cryo-probe. Suppression of the water 
signal was accomplished by excitation sculpting sequence [152]. Two dimensional 
NOESY [153-154], TOCSY [155] and DQF-COSY [156] spectra were acquired at very 
high digital resolution, using standard pulse sequences. NOESY spectra were acquired 
using mixing times ranging from 80-150 ms. TOCSY experiment was performed with 
spin lock applied for 60 ms. Spectra were processed using Bruker TOPSPIN software and 
analyzed on SGI Octane workstation with the CARA program [157]. The 1H chemical 
shifts (in ppm) of di-Zn(II)-DF3 complex are reported in Table 9. 
 
 
 
 
 
Chapter 2 - De novo design of a di-iron catalytic model: DF3  
 
 
 - 58 - 
Table 9. 1H chemical shifts (in ppm) of di-Zn(II)-DF3 at 298 K and pH 6.1a 
Section 1.01 aChemical shifts were referenced to the internal TSP. 
 
  
 HN Hα Hβ Hγ Hδ others 
 
Ace 
  1,84     
1 ASP D 8.38 4,37 2,64    2,47    
2 TYR Y 7.70 4.17 3.00    2.91   Hδ1,2 6.94  Hε1,2 6.61 
3 LEU L 7.31 3.86 1.79 1.18  δ,δ' CH3  0.79 
4 ARG R 7.69 3.83 1.88    1.76 1.50 3.13 HNε   7.35 
5 GLU E 7.84 3.99 1.96    1.82 2.22   
6 LEU L 7.72 1.92 1.68   1.16 1.68  δ,δ' CH3   0.60, -0.12 
7 LEU L 7.91 3.84 1.87 1.45  δ,δ' CH3   0.92, 0.86 
8 LYS K 7.95 3.85 1.93 1.32 1.65 εε' CH2   2.89 
9 GLY G 7.96 4.11   3.83     
10 GLU E 8.31 4.43 2.14 2.58 2.32   
11 LEU L 8.57 4.00 1.91    1.71 1.39  δ,δ' CH3  0.73 
12 GLN Q 7.88 4.06 2.14 2.38  HNε1,2 7.43, 6.82 
13 GLY G 8.19 3.83     
14 ILE I 8.43 3.79 1.89 1.64 1.05  γCH3 0.88   δ,δ' CH3 0.72 
15 LYS K 7.26 3.89 2.08 1.49 1.79  
16 GLN Q 7.52 4.06 2.09    1.93 2.43 2.29  HNε1,2  7.28, 6.57 
17 TYR Y 9.21 4.00 2.96    2.74   Hδ1,2 6.85   Hε1,2  6.58  Hη 9.05 
18 ARG R 8.67 3.79 1.85    1.76 1.55 3.05 HNε   7.05 
19 GLU E 7.62 3.86 2.02    1.88 2.32   
20 ALA A 7.95 3.71 1.39    
21 LEU L 8.59 3.98 1.76    1.49 1.90  δ,δ' CH3  0.78, 0.73 
22 GLU E 7.51 3.78 1.86    1.46 2.05   
23 TYR Y 7.20 4.38 2.84   Hδ1,2  6.81   Hε1,2  6.63 
24 THR T 7.74 4.28 4.13 1.22   
25 HIS H 8.70 4.22 3.24   Hδ2  7.04   Hε1 8.26 
26 ASN N 7.28 4.81 2.65   HNδ1,2  8.13, 6.71 
27 PRO P  4.20 2.26 1.95   1.86 4.00  3.74  
28 VAL V 8.05 3.36 1.81   γ,γ' CH3  0.74, -0.67 
29 LEU L 7.33 3.87 2.02    1.63 1.36 0.88  
30 ALA A 7.16 3.87 1.35    
31 LYS K 7.80 3.83 1.74 1.84  1.28 1.58 ε,ε’ CH2 2.82 
32 ILE I 7.84 2.86 1.18 0.94  γCH3 -0.49   δCH3 0.47 
33 LEU L 7.82 3.34 1.65 1.36  δ,δ' CH3 0.80 
34 GLU E 7.24 3.98 2.03    1.77 2.34   
35 ASP D 7.41 4.00 3.09    1.97    
36 GLU E 8.20 4.14 1.93    1.60 2.55  2.22   
37 GLU E 8.05 3.70 1.95    1.78 2.39   
38 LYS K 6.99 3.64 1.09 0.50 1.46 εε' CH2  2.70, 2.45      HNζ  7.46 
39 HIS H 7.92 3.90 3.49    2.85   Hδ2  6.09   Hε1  7.34     HNε2  15.16 
40 ILE I 7.79 3.58 1.90 1.54 1.19  γCH3 0.81  δCH3 0.73 
41 GLU E 7.15 4.04 2.09 2.37   
42 TRP W 8.81 4.65 3.46   3.05   Ηδ1  7.14  Ηε1 10.17  Hε3 7.25  Hζ3 6.71   Hζ2 7.46   Hη 7.21 
43 LEU L 8.77 4.03 2.03 1.16  δ,δ' CH3  0.93, 0.86 
44 GLU E 8.80 3.93 2.18   1.92 2.53  2.11   
45 THR T 8.17 4.00 4.46 1.22   
46 ILE I 7.72 3.79 1.71 1.15  γCH3  0.86   δCH3  0.79 
47 LEU L 8.15 3.98 1.73 1.53  δ,δ' CH3  0.86, 0.75 
48 GLY G 7.80 3.86     
49 NH2        
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2.3.2.b NMR structure calculation and refinement 
Intensities of dipolar connectivities in the two-dimensional NOESY spectrum, 
obtained using a 150 ms mixing time, were measured using the integration subroutine of 
the CARA program. Peak volumes were converted into upper limits of interatomic 
distances, to be used as input for structure calculations, by following the methodology of 
the program CALIBA [158]. The di-Zn(II)-DF3 structure was calculated with the 
program CYANA [159] (version 2.1), by using a total of 1,402 experimental restraints 
(15 per residue, including 2 x 230 intraresidue, 2 x 185 sequential, 2 x 152 medium-
range, 174 intermonomer, and 2 x 47 intramonomer NOEs) (Table 5). The di-Zn(II) site 
was treated the same as previous dimeric DF structures [55, 57]: the CYANA standard 
library was modified by defining an artificial His residue containing a zinc atom 
covalently bonded to its N
δ
. The geometry of the other coordinating residues (Glu10 and 
Glu36) was restrained by upper and lower distance limits. Typical CYANA runs were 
performed on 200 randomly generated starting structures with 10,000 torsion angle 
dynamics steps. The 40 CYANA structures with the lowest target function were then 
subject to further refinement by using the Sander module of AMBER 7.0 with the 1999 
version of all-atom force field [160].  
During the energy minimizations, the solvation effects were implicitly included using the 
pairwise GB-model as implemented in Amber 7 [161]. Distance restraints were applied 
as a flat well with parabolic penalty within 0.5 Å outside the upper bond, and a linear 
function beyond 0.5 Å, using a force constant of 32 kcal mol-1·Å-2 for the distance 
constraints. The best 30 structures (Figure 17f) among those with a total Amber energy 
lower than -4,801.2 kcal·mol-1 and with a residual distance-constraint energy lower than 
56.4 kcal·mol-1 were selected to represent the solution structure for di-Zn(II)-DF3. The 
average Amber energies of the NMR bundle were: total energy: -4,904.21 ± 50.21 ·mol-1; 
distance constraints: 42.56 ± 4.18 ·mol-1; Van der Waals -668.49 ± ·mol-1. The quality of 
the obtained structures was evaluated in terms of deviations from ideal lengths and bond 
angles through a Ramachandran plot obtained using the program PROCHECK-NMR 
[162]. Analysis of the ensemble of the structures revealed that 90.0 % of backbone angles 
fall within the most favored regions of Ramachandran plot, 9.5 % in additional allowed 
regions and 0.50 % in the generously allowed regions. The structural statistics for the 30 
final NMR structures are reported in Table 5. 
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2.3.3 UV–vis analysis 
UV–vis spectra were recorded with a Cary 50 UV–vis–near IR spectrophotometer 
equipped with a thermostatted cell compartment (Varian, Palo Alto, CA, USA) using 
quartz cuvettes with 1- or 0.2-cm path lengths. Wavelength scans were performed at 25 
°C from 200 to 800 nm, with a 60 nm·min-1 scan speed. Extinction coefficients are 
expressed per dimetal site unless noted otherwise.  
 
2.3.3.a Preparation of the metal complexes and azide binding studies 
Both protein and metal stock solutions were freshly prepared. The initial DF3 
concentration was determined spectrophotometrically using ε280 = 19,060 cm-1·M-1 (per 
dimer) [163]. Metal ion concentrations in the pure DF3 complex and in the metal stock 
solutions were measured by a Varian Spectra AA 220 atomic absorption spectrometer, 
equipped with an MK7 burner.  
The Co(II)–DF3 complex was prepared by adding 1.05 equiv (with respect to the 
monomer) of CoCl2 (from an aqueous stock solution) to the DF3 solution (at a 
concentration in the range 70–100 µM) in a 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) buffer (50 mM HEPES, 100 mM NaCl, pH 7.0). 
In the case of the di-Fe(III)–DF3 complex, 1.05 equiv of Mohr’s salt (in 0.1% H2SO4 
water solution) was added dropwise to an aqueous solution of DF3 (0.25 mM pH 3.0). 
The pH was then raised to 7.0 by addition of buffer (200 mM HEPES, 200 mM NaCl, pH 
7.0) and the mixture was incubated for 1 h at room temperature under atmospheric 
oxygen. The protein solution became pink during the incubation period, and a small 
quantity of precipitates, presumably iron oxides and aggregated protein, appeared. The 
solution was centrifuged to remove these precipitates and any excess of residual free 
metal salts in the supernatant was removed using a Vivaspin filter (5,000 molecular 
weight cutoff) (Vivascience, Edgewood, NY, USA). Pure complexes were obtained after 
three cycles of washing with the appropriate buffer solution. For the azide titration 
studies, aliquots of 3 · 10-3 g of NaN3 were added to a 200 µL solution of freshly prepared 
di-Fe(III)-DF3 (78 µM) in 50 mM HEPES, 0.1 M NaCl, pH 7. Following each addition, 
the mixture was mixed for 5 min, and its UV–vis spectrum was acquired at 25 °C. This 
process was repeated until the concentration of NaN3 in the sample was 2.4 M. 
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2.3.3.b Catalytic assays 
Complete conversion of the di-Fe(III)-DF3 complex to the reduced form was 
accomplished by the addition of sodium dithionite. A solution of di-Fe(III)-DF3 complex 
in buffer was made anaerobic by several cycles of flushing with argon. 1.5-fold excess of 
a dithionite solution was added, and the resulting solution was incubated under argon for 
30 min. Re-oxidation of the diferrous complex was easily obtained upon exposure to 
atmospheric oxygen under stirring. The UV-vis spectra of the DF3 di-iron complexes in 
the ferric and ferrous forms are illustrated in the Figure 21. 
All the catalytic assays were performed in 100 mM HEPES, 100 mM NaCl, pH 7.0 at 
25 °C. The experiments were followed using a Varian Cary 50 spectrophotometer, by 
measuring the appearance of the products in the reaction medium. Reference cuvettes 
contained all of the components, except the substrate, in a final volume of 0.5 ml.  
The substrates used in the catalytic assays were 3,5-DTBC, 4-AP, PPD and OPD. 
Stock solutions of each substrate were prepared in different solvents, depending on their 
solubility. The appropriate amount of the substrate solution was added to the di-Fe(III)-
DF3 solution, and the starting time was set at this point. The experiments were followed 
at the wavelength corresponding to the absorption maximum of the product. In details, 
the experimental conditions for the catalytic assays with the different substrates are as 
follows.  
4-aminophenol (4-AP): di-Fe(III)-DF3 2.0 µM; stock solution of 4-AP was prepared 
in dimethylformamide in the range of 0.1 - 3 mM; the experiments were done in the 
presence of 10 mM m-phenylendiamine [164]. 4-amino-phenol was oxidized to the 
corresponding benzoquinone mono-imine. Benzoquinone mono-imine was detected as 
aminoindoaniline by reaction with m-phenylendiamine (Scheme 1). 
The formation of the aminoindoaniline dye was measured at  λmax = 528 nm, using the 
ε value of 10,700 M-1·cm-1 , taken from the literature [151]. For this substrate, di-Fe(III)-
DF3 protein showed multiple turnover kinetic. Measurement of the reaction over the 
course of an hour indicated that the protein was capable of at least 50 turnovers. 
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Scheme 1 
 
3,5-di-tert-butylcathecol (3,5-DTBC): di-Fe(III)-DF3 13 µM; stock solution of 3,5-
DTBC was prepared in methanol in the range of 0.1 mM - 2 mM; the formation of 3,5-
ditert-butylquinone (3,5-DTBQ) was measured at λmax = 400 nm, using the ε value of 
1,040 M-1·cm-1, experimentally determined in the kinetics conditions, using commercially 
available 3,5-DTBQ (Scheme 2). 
.  
 
 
 
 
 
 
 
   3,5-DTBC        3,5-DTBQ 
Scheme 2 
 
p-phenylenediamine (PPD): di-Fe(III)-DF3  2.0 µM; stock solution of PPD was 
prepared in dimethylformamide in the range of 0.2 - 5 mM; the experiments were done in 
the presence of 10 mM aniline [151] . The formation of phenosafranine was measured at 
NH2
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λmax = 519 nm, using the ε value of 29,313 M-1·cm-1, experimentally determined in the 
kinetics conditions (Scheme 3). 
Initial velocities were extracted from the steady-state portion of the progress curves 
(first 30 s after addition of the substrate). Kinetic parameters (vmax, Km and kcat) were 
obtained assuming a Michaelis-Menten model and determined from a Lineweaver-Burk 
plot (Figure 30). The oxidation products (3,5-DTBQ and phenosafranine) were also 
identified by ESI-MS spectrometry.  
p-PD p-benzoquinonediimine aniline PHENOSAFRANINE
 
Scheme 3 
 
2.3.3.c ESI-MS analysis of oxidation products 
The oxidation products derived from the kinetic measurements of 3,5-DTBC and 
PPD (3,5-DTBQ and phenosafranine) were identified by ESI-MS spectrometry. ESI-MS 
spectra were recorded on a Shimadzu LC-MS-2010EV system with ESI interface, and 
Shimadzu LC-MS solution Workstation software for the data processing. A Q-array-
octapole-quadrupole mass analyzer was used as the detector. The mobile phase, at a flow 
rate of 0.2 mL·min-1, was made up of acetonitrile containing 0.1% formic acid. The 
optimized MS parameters were selected as followed: CDL (curved desolvation line) 
temperature 250 °C; the block temperature 250 °C; the probe temperature 250 °C; 
detector gain 1.6kV; probe voltage +4.5kV; CDL voltage -15V. Nitrogen served as 
nebulizer gas (flow rate: 1.5 L·min-1). In order to avoid perturbation of the ESI-MS 
analysis by HEPES buffer, the reaction products were extracted from the reaction mixture 
with CH2Cl2. The organic solution was dried, and the product dissolved in methanol. 
ESI-MS spectrum for the 3,5-DTBQ shows a peak m/z, 220.85, which corresponds to the 
expected mass for the quinone. The ESI-MS spectrum for the oxidation product of PPD 
shows the most abundant peak at m/z 286.95, which corresponds to the expected mass for 
phenosafranine. 
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2.3.4 DF3: Circular dichroism analysis 
Circular dichroism (CD) measurements were performed at 25 °C, using a J-750 
spectropolarimeter equipped with a thermostated cell holder (JASCO, Easton, MD, 
USA). Cells of 0.5-cm path length were used in all measurements. Mean residue 
ellipticities [θ] were calculated using the equation [θ] = θobs/(10 · l · C · n), in which θobs is 
the ellipticity measured in millidegrees, l is the path length of the cell in centimeters, C is 
the concentration in moles per liter, and n is the number of residues in the protein. Metal 
ion titrations were carried out by adding small aliquots of freshly prepared aqueous stock 
solutions of MCl2 (M is Co, Mn, or Zn) to the protein solution (protein concentrations in 
the range 12–16 µM per monomer, in 10 mM phosphate buffer at pH 7). The variations 
in protein concentration and pH were negligible. Samples were left to equilibrate for 30 
min before measurement. Metal-binding data were subjected to a nonlinear least-squares 
analysis, using KaleidaGraph (Synergy Software, Reading, PA, USA).  
 
2.3.4.a   Chemical denaturation 
Chemical denaturation studies were performed on samples containing apo-DF3 at 8–
10 µM concentration per monomer, in 10 mM phosphate buffer at pH 7.2, 10 mM NaCl 
and increasing amounts of guanidine hydrochloride (Gdn·HCl) (0–6 M, with 
approximately 0.3 M increments). For the denaturation studies in the presence of metal 
ions, the solutions contained an approximately 100-fold excess of metal ions. Samples 
were left to equilibrate for 12 h before measurement. Gdn·HCl denaturation curves were 
obtained by monitoring the CD signal at 222 nm upon Gdn·HCl addition, with a 60 s 
averaging time. Data were normalized as the fraction unfolded (fu), calculated as fu = (θobs 
– θ0)/( θ∞ – θ0), in which θobs, θ0, θ∞  represent the ellipticity at the actual Gdn·HCl 
concentration, at zero Gdn·HCl concentration, and of the unfolded protein, respectively. 
The data curves were fit to the equation for dimerization-linked folding [53, 165-167], 
using KaleidaGraph: 
Df ↔ Mu 
in which Df is the folded dimer in equilibrium with the unfolded monomers, Mu. The data 
were analyzed by the linear extrapolation method using the following equation: 
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in which θu°, θf°, au, and bf are the molar ellipticities and the slopes of the baselines for 
the monomeric and dimeric protein, respectively; ∆GuH2O is the free energy of 
dimerization and folding (1 M standard state) extrapolated to 0 M Gdn·HCl, and m is the 
linear change in ∆G°  with respect to the Gdn·HCl concentration. 
 
2.3.5 Resonance Raman studies 
Resonance Raman spectra were collected with an Acton AM-506 spectrometer using 
a Princeton Instruments liquid-N2-cooled CCD detector (LN-1100 PB) with 4 cm-1 
spectral resolution. Laser excitation (514.5 nm) was provided by a Spectra Physics 2065-
75 argon ion laser. Spectra were obtained at 80–100 mW power in a 90° backscattering 
geometry using spinning flat-bottomed NMR tubes. Spectra were typically collected 
using 64 accumulations of 60 s each. Thus, laser exposure in each experiment totaled at 
least 1 h. Samples were somewhat sensitive to photodecomposition under these 
conditions, based on the decrease of the absorbance at 490 nm following laser exposure. 
Raman shifts were referenced to indene and are accurate to approximately 1 cm-1. 
Baseline correction and curve fitting to determine peak positions were carried out using 
Grams/AI Spectral Notebook, version 7.02 (Thermo Galactic). 
 
2.3.6 Electron paramagnetic resonance studies 
EPR spectra were measured in perpendicular mode at -269 °C (liquid helium 
temperature) on a Bruker Elexsys E-500 spectrometer equipped with an Oxford ESR-910 
cryostat. All EPR spectra were collected at 9.64 GHz using a power of 2.0 mW, a 
modulation amplitude of 10 G, and a modulation frequency of 100 kHz. EPR 
experiments were performed on samples containing di-Fe(III)-DF3 at 2.2 mM 
concentration. A high-spin Fe(III) EPR spin standard was examined under identical 
conditions, in order to compare the intensity of the g = 4.3 signal of this spin standard 
with that of di-Fe(III)-DF3. 
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3.1 Results  
3.1.1 Design of first analogue MP1 
 In this thesis we report the de novo design procedure of MPs, a new class of heme-
peptide based models, which have been developed to show HRP- or cytP450-like 
activities, using H2O2 as oxidizing agent. De novo design was based on the structural and 
functional properties of natural proteins HRP and cytP450. This step was crucial, because 
we aimed to obtain a five-coordinated model, able to bind and activate the peroxide. 
To design the first model MP1, we examined the structure of Bacterioferritin, which 
is an oligomeric protein containing both a binuclear iron center and a heme b. BFR forms 
a roughly spherical, hollow shell from 24 identical subunits, incorporating 12 heme 
groups. Each subunit comprises a bundle of four long α helices (A to D) and a short helix 
(E), which together account for approximately 75% of the total secondary structure. The 
heme group is located between two subunits that form the dimer, with a methionine from 
each monomer providing an axial ligand to the heme iron [168] (Figure 31).  
 
 
 
 
 
 
 
 
  a)    b)    c) 
Figure 31: crystal structure of BFR. a) The molecular weight of protein shell is 445,000 and its 24 
subunits are arranged in 432 symmetry to form a nearly spherical hollow shell; b) schematic representation 
of a single subunit; c) the structure is constituted by 24 four-helix bundle and 12 heme, each one located 
between two subunits that form the dimer. 
 
In our initial effort, we chose to analyze the single dimeric subunit, and in particular 
the heme-facing helices of BFR. From this highly-symmetric system, we picked out the 
minimum number of residues necessary to cover the porphyrin group and the position for 
the loop insertion, obtaining an helix-loop-helix/heme/helix-loop-helix antiparallel system 
(Figure 32).  
 
E  D  C      A  B 
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   a)    b)     c) 
Figure 32: de novo design of MP1 a) overall structure of BFR, in which a dimer is highlighted; b) a single 
dimer subunit; c) final helices considered to design MP1. 
 
We left the orientation between the helices and the heme unchanged, but the parent 
sequence of BFR was modified as in the following: 
1. one of the two coordinating Met residues was replaced by a homo-Cys residue, 
mimicking cytP450-like coordination; the second Met residue was replaced by a smaller 
residue, such as serine, unable to coordinate the metal ion (Figure 33). 
 
 
 
 
 
 
Figure 33: superimposition of active sites of cytP450 (in orange color) and MP1 model (in green and 
atom-color): the coordinating S-atoms point the metal ion in the same way.  
 
2. protoporphyrin IX was substituted with deuteroporphyrin IX to avoid degradation of 
the sensitive vinyl substituents during the synthesis. 
 
3. active-site cavity was engineered on the basis of HRP structure: an Arg residue 
(corresponding to R38 of HRP) was modeled at the right distance from the metal center 
(Figure 34). 
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Figure 34: superimposition of active sites of HRP (in pink color) and MP1 model (in green and atom-
color): the distal arginine residues are positioned at the same distance from the metallic center. 
 
4. two inter-chain ion pairing residues were inserted into the sequence to stabilize the 
structure and to overcome the problem of multiple diastereomer formation, as already 
described for Mimochrome IV (Figure 35) [50].  
 
Figure 35: NMR structure of Co(III)-MimoIV; inter-helical Glu1/Arg9 pairs are reported. 
 
In a first step two pairs of arginine and glutamic acid were introduced according to 
intrinsic helix dipole: the negative residue was placed at the N-terminus of the helix, and 
the positive residue at the C-terminus. In a second step, one inter-chain electrostatic bond 
was inverted, positioning the Arg residue at access channel to the active site, which could 
facilitate peroxide transport; subsequently the Glu residue was replaced by an Asp and re-
modeled to optimize charge groups interactions on the same plane. 
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5. a ‘‘Rose-like’’ αL–β loop was engineered to obtain a single chain from two antiparallel 
helices [169]. The loop sequence Thr-Asn-Glu was selected, as suggested by our studies 
on inter-helical loops in DF models [10]. In particular, Asn residue was selected to 
stabilize the C-capping motif [93], Thr allows a sharp turn in the peptide backbone and 
prevent helix propagation [94], and Glu, located near the N-terminus of the second helix, 
was selected as N-capping residue [95] (Figure 36).  
 
 
 
 
 
 
 
 
 
 
Figure 36: the Rose-like inter-helical loop selected in MP1. N-cap motif: Glu22C=Oε----HN Glu24/25; C-
cap motif Thr20NH----O=C Lys16, Asn21NH-----O=C Val17, Asn21NHδ----O=C Val17/LEU18. 
 
6. N- and C-terminal ends were acetylated and amidated, respectively, in order to avoid 
unfavorable end-charge to helix-dipole interactions. A N-cap motif was introduced as 
helix-initiator, in which the backbone amide group of the first residue H-bonds the side 
chain of i+3 residue (Figure 37). 
 
 
 
 
 
 
 
 
 
Figure 37: the N-cap and C-cap terminating motif in MP1.  The sequence Asp-Pro-Gly-Thr was 
selected on the basis of amino acids statistical preferences in this motif. 
N-cap C-cap 
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7. the amino acid sequence was selected to maximize the burial of hydrophobic side 
chains, and their interaction with the heme group, while simultaneously exposing 
hydrophilic side chains to solvent, to ensure the overall solubility (Figure 38). 
Observations of native and designed proteins have allowed some general folding 
principles for α-helical assemblies to be elucidated. In particular, the major factor that 
controls the formation of helical proteins is the periodicity of hydrophobic (nonpolar) and 
hydrophilic (polar) residues within the sequence, which can be considered as a type of 
binary pattern: a spacing of hydrophobic residues three or four residues apart leads to the 
formation of an amphipathic α-helix. 
 
 
 
 
 
 
 
   a)        b) 
 
 
 
 
 
   c)    
Figure 38: surface representation of MP1 a) internal surface, with hydrophobic residues colored in grey 
b) external surface, with hydrophilic residues colored in red (acid residues), blue (basic residues) and green 
(neutral residues); c) surface representation of the overall structure, colored as in a) and b).  
 
 
8. bulky residues such as Trp and Phe were introduced to be buried inside the active site 
while fitting the available space; then, different shapes and dimensions of side chain 
residues were introduced to improve the steric complementarity of the helix-helix 
interfaces (Figure 39). 
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Figure 39: surface representation of MP1 model, which highlights the shape complementarity into the 
helix-helix packing and into the helix-heme interface. 
 
The designed heterodimer shows the following features: 
(i)  the proximal site is rich of Leu residues, which is known to have a high preference for 
the α-helical conformation, and to maximize the hydrophobic interactions with the 
heme group; 
(ii) the distal site is rich of smaller residues, such as Gly, to create a cavity large enough 
to accommodate an organic substrate; furthermore, the low steric hindrance may 
provide to the catalytic Arg sufficient conformational mobility to bind and transport 
the peroxide ion to the active site. 
To further stabilize this model, the peptide chains were covalently linked to the porphyrin 
propionic group through the ε-amino function of two Lys residues. We expected the 
covalent attachment of peptide chains to the porphyrin to improve the tertiary structure 
formation. Porphyrin ring re-orientation was necessary to position the propionic groups 
closer to the distal helices. Molecular modeling showed that changing the side chain 
conformation of Lys10 and the conformation of the closest propionyl carboxyl group, the 
lysine ε-amino group may approach the propionyl carboxyl group at bonding distance.  
Computational methods based on molecular mechanics were applied to refine the 
structure into a local energy minimum. Only energy-allowed rotamers were accepted. 
These methods, alternated to redesign iterative phases, led to a final model structure of 
MP1. It is made up of two 41-residue helix-loop-helix (α2) motifs, assembled into an 
antiparallel four-helix bundle, with a covalently bound deuteroporphyrin housed in the 
bundle interior. The amino acid sequences are reported in Figure 40, while the molecular 
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model is depicted in Figure 41. The two peptide chains are differently named. The 
peptide chain with the coordinating homo-Cys is named ChainJ and the second chain is 
named ChainK.   
  distal helix     loop   proximal helix 
Chain J Ace-DPGTFEQQLKQLWDKVLK-TNE-PEEEKQLIQICEQLLKRLDK-NH2 
 
 
 
 
 
Chain K Ace-DPGTFEQQLKQLRDKVLK-TNE-PEERKQIGQISEQLFKRLRG-NH2 
Figura 40: MP1 sequence. Main differences in amino acid composition are color highlighted: inter-chain 
ion pairing are colored in pink, residues which face the heme group are colored in yellow, the coordinating 
homo-Cys is highlighted in red and catalytically involved residues are in blue. 
 
 
 
 
 
 
 
 
 
 
 
Figure 41:  3D molecular model of Fe-MP1. Ribbon representation of the peptide chain which brings the 
coordinating homo-Cys is colored in magenta, while the chain with catalytically involved residues is 
colored in yellow. Residue colors are based on their type, as in Figure 38. The homo-Cys coordinating 
residue and the heme group are colored in yellow and pink, respectively. 
 
3.1.2 Synthesis of MP1 
An important endeavor of this work was the development of a versatile strategy for 
the synthesis of covalent heme-peptide conjugates, to obtain in high yields and purity. 
MP1 analogue was synthesized by means of both solution and solid-phase peptide 
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methods [170-171], coupling the fully protected peptides – except for Lys10- with the 
deuteroporphyrin IX.  
The classical N-α-Fmoc protocol was adopted [172] using a Sieber resin [173] (Figure 
42).  
O
OHN
O O
 
Figure 42: 9-Fmoc-amino-xanthen-3-yloxy TG resin 
 
The synthetic procedure developed for MP1, which is the result of a refinement 
procedure, is composed of several experimental cycles. After the solid-phase synthesis 
(step A), we removed the Mmt group of Lys10 (Figure 43) leaving the two peptides fully 
protected (step B); the ChainK was coupled to deuteroporphyrin IX in heterogeneous 
phase (step C). Then, the monosubstituted deuteroporphyrin IX+ChainK and the ChainJ 
were cleaved from their solid support (step D), and the final coupling between the 
protected pepdides was performed in solution (step E). After completion of the molecular 
assembly, all the protecting groups were removed by acidic treatment (step F) and the 
crude product was analyzed and purified. After each step, the product was purified and 
then fully deprotected with strong acids to be analyzed via LC-MS. 
 
Figure 43: Fmoc-Lys(Mmt)-OH. 
PEG 
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The synthetic procedure (Figure 44) can be summarized as follows: 
NH(Mmt) NH2
O
OH
O
N
NH N
HN
NH
D)
O
OH
O
N
NH N
HN
NH
OO
N
NH N
HN
NH
N
H
NH(Mmt)NH2
NH2
A) B)
C)
A)B)
D)
E)
OO
N
NH N
HN
NH NH
F)
 
Figure 44: synthetic procedure developed for MP1. ChainK is colored in orange, while ChainJ in pink; 
Protecting groups are depicted as spheres, and the unprotected side chain groups as stars. 
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Chain K: 
A) Solid phase synthesis of ChainK  
B) Selective deprotection of Mmt group on Lys10  
C) Coupling of  DEU IX and ChainK in solid phase 
D) Cleavage of mono-adduct ChainK(protected)+DEU and purification 
 
Chain J 
A’) Solid phase synthesis of ChainJ  
B’) Selective deprotection of Mmt group on Lys10  
C’) Cleavage of ChainJ(protected) 
E ) Coupling of ChainK(protected)+DEU with ChainJ(protected) in solution 
F ) Final deprotection of the dimer ChainJ-DEU-ChainK 
 
 
The most difficult step of the MP1 synthesis was the preparation of the final dimer: in 
this step we used two different coupling agents, HATU [174] and HOSU in the presence 
of DCC [175]. Unfortunately, both procedures didn’t give the expected results: LC-MS 
analysis of fully deprotected peptides revealed the contemporary presence of the free 
monomers and of the dimer in a complex mixture (Figure 45).  
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Figura 45: HPLC chromatogram of coupling mixture. Peak at t=47.33min corresponds to 
ChainK+DEU, peak at t=52.78min corresponds to ChainJ, and peak at t=53.75 min is the 
ChainK+DEU+ChainJ. 
K+DEUIX 
K+DEUIX+J 
J 
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We tried to isolate the desired product after the insertion of iron in the porphyrin 
macrocycle, using iron(II) acetate as metal carrier [176]. The reaction was followed by 
HPLC (Figure 46). 
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Figure 46: HPLC chromatogram of coupling mixture before (t=0) and after iron insertion (t=1h). 
The final mixture was very complex and the difficult purification led to low yields.  
Then, we developed a new synthetic strategy, starting from MP1 fragments: with this 
procedure, we verified if the steric hindrance of the chains should prevent their mutual 
coupling. 
 
3.1.2.a Synthesis of MP1 fragments 
The new strategy consisted of the partial synthesis of the peptides: the solid phase 
synthesis was stopped at Lys10, leaving its Nα-Fmoc group intact. The main difference 
was the coupling of the mono-adduct peptide+DEU, anchored to its solid support, with 
TIME=0 
TIME=1h 
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the other peptide; done this, the SPPS could be completed, because of the identity of two 
sequences. We applied this protocol twice, obtaining both mono-adduct ChainK+DEU 
and ChainJ+DEU, performing all combination summarized in Figure 47. Synthetic 
phases are the same of the first protocol, except for step D, which was eliminated, and 
step E, which was conducted in heterogeneous phase; step F should be performed after 
final elongation of the peptide chains. 
 
 
Figure 47: all possible combinations in the synthetic protocol of MP1 fragments. ChainK is colored in 
orange, ChainJ in pink.  
1: SPPS of resin+K+DEU; cleavage of K(protected)+DEU; coupling of 
K(protected)+DEU with resin+J; 
2: SPPS resin+K+DEU; clevage of J(protected); coupling of J(protected) with 
resin+K+DEU; 
3: SPPS resin+J+DEU; clevage of K(protected); coupling of K(protected) with 
resin+J+DEU; 
4: SPPS of resin+J+DEU; cleavage of J(protected)+DEU; coupling of J(protected)+DEU 
with resin+K. 
Unfortunately, combinations 1 and 4 didn’t give any detactable product. This 
procedure demonstrated that the most difficult step is the coupling between the porphyrin 
and the peptide, regard its sequence.  
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3.1.3 Synthesis of MP2 
Consequently, we designed a new analogue, MP2. The following substitutions were 
made on MP1 sequence: 
(i) Lys(Mmt) position was moved closer to N-terminus, to evaluate its influence on the 
bond formation with the porphyrin; 
(ii) some Arg residues, which are somewhat difficult to couple [177], were replaced with 
Leu residues, to improve the purity of the crude product;  
(iii) Leu residues were preferred because of their high propensity to be accommodated in 
α-helical conformation and because the hydrophobic interactions, between the 
leucine side chains and the porphyrin, would drive the helices to lay on the porphyrin. 
(iv) the inter-chain ion pair between Arg40 in the ChainK and Glu25 in the ChainJ was 
removed. Two leucines replaced these residues. The ChainK was reduced to 40 
residues. 
Figure 48 shows MP2 sequence, highlighting the substitution made on MP1 sequence. 
distal helix     loop   proximal helix 
Chain J Ace-DPGTFKQQLLQLWDKVLK-TNE-PEELKQLIQICEQLLKLLDK-NH2 
 
 
 
 
 
Chain K Ace-DPGTFKQQLLQLRDKVLK-TNE-PEERKQIGQISEQLFKLLG-NH2 
Figure 48: MP2 sequence, with the substitution made on MP1 sequence highlighted in yellow. 
 
For MP2 synthesis, we adopted the same strategy described for MP1. LC-MS 
analysis of the two peptides, cleaved fully deprotected from the resin, revealed their 
identity. The high purity of both crude products was encouraging to obtain high yields of 
the final dimer (Figure 49). 
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        a)           b) 
Figure 49: LC-MS chromatogram of crude peptides. a) ChainJ and b) ChainK 
After coupling reaction between ChainK and DEUIX (see Figure 44, step D), the 
analysis via LC-MS gave an important result: the contemporary presence of mono-adduct 
K+DEU and the di-adduct K+DEU+K (Figure 50). This result could explain the difficult 
formation of the covalent bond between ChainK+DEU and ChainJ in MP1 synthesis: the 
high resin substitution led to the formation of several peptide chains on each support, 
creating a so busy population that the entry of another peptide or his bond was inhibited. 
Moreover, using a relatively low excess of DEUIX, most free amino sites on lysines were 
occupied, leading to the formation homo-dimer than the monomer. In these conditions, 
the position of Lys residue in the sequence didn’t affect the coupling reaction, more 
influenced by mutual steric hindrance of overall peptide chains. 
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Figure 50: HPLC chromatogram of coupling mixture between MP2-ChainK and DEUIX. Peak at 
t=53.95min corresponds to mono-adduct K+DEU, while the peak t=54.49 corresponds to dimer 
K+DEU+K. 
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The purification of this mixture was very laborious, so it has been attempted to 
enhance the yield of these products by alternative strategies. Moreover, we decided to 
replace the homo-Cys coordinating residue with a His residue: protection of the β-thiol of 
cysteine for use in SPPS has long been recognized as imperative, due to the high degree 
of nucleofilicity of bivalent sulfur as well as to the ready tendency for oxidation to 
disulfides. In this way, we should avoid side-reactions and reproduce the coordination 
chemistry of natural protein HRP. 
 
 
3.1.4 Synthesis of MP3 
The last analogue MP3 presents in its sequence (Figure 51-52): 
(i) an His coordinating residue, aimed to reproduce the HRP coordination chemistry; 
(ii) a Thr residue in position 10, whose hydroxyl group should H-bond the carbonyl 
group of DEUIX propionates; 
(iii) an Asp residue in position 9, which should improve the imidazolate character of the 
coordinating His, as in HRP proximal site. 
distal helix      loop   proximal helix 
Chain J Ace-DPGTFKQQDTQLWDKVLK-TNE-PEELKQLIQIHEQLLKLLDK-NH2 
 
 
 
 
 
Chain K Ace-DPGTFKQQLTQLRDKVLK-TNE-PEERKQIGQISEQLFKLLG-NH2 
Figure 51: MP3 sequence, with the substitution made on MP2 sequence highlighted in green. The 
main differences involve the proximal site defined by ChainJ. 
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Figure 52:  3D molecular model of Fe-MP1. Ribbon representation of the peptide chain which brings the 
coordinating His is colored in magenta, while the chain with catalytically involved residues is colored in 
yellow. Residue colors are based on their type.  
 
As for MP2, LC-MS analysis of the two peptides, cleaved fully deprotected from the 
resin, revealed their identity; the high purity of both crude products was encouraging to 
obtain high yields of the final dimer (Figure 53). 
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   a)      b) 
Figure 53: LC-MS chromatogram of MP3 crude peptides. a) ChainK and b) ChainJ. 
The final protocol adopted is shown in Figure 54: the main difference consists in the 
reaction between the ChainK and DEUIX, which is conducted in solution. The peptide, 
after removal of Mmt group, was cleaved from its solid support in a fully protected form, 
and coupled to a large excess of DEUIX. Gel-filtration chromatography was utilized to 
remove the DEUIX excess, and the LC-MS analysis of the reaction product revealed the 
presence of the mono-adduct ChainK+DEUIX. After purification, the reaction between 
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ChainK(prot)+DEUIX and ChainJ(prot)-Mmt was conducted in solution, utilizing a 50% 
excess of ChainJ. The crude product was analyzed by LC-MS.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 54: synthetic procedure improved for MP3. ChainK is colored in orange, while ChainJ in pink; 
Protecting groups are depicted as spheres, and the unprotected side chain groups as stars. 
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3.1.5 Characterization of MP3  
Iron ion was inserted into crude MP3 according to literature procedures [176], and the 
reaction monitored by analytical HPLC (Figure 55). The crude product was purified to 
homogeneity by preparative RP-HPLC, and LC-MS confirmed the expected molecular 
weight (10168 ± 7 amu) (Figure 56). 
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Figure 55: HPLC chromatogram of coupling mixture before (t=0) and after iron insertion (t=1h). 
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Figure 56: LC-MS chromatogram of pure Fe-MP3, and its mass spectra. 
 
 
3.1.5.a CD studies 
CD spectroscopy was used to analyze the secondary structure of Fe(III)-MP3. The 
far-UV CD spectrum of this complex indicates the protein to be in α helical 
conformation, in the 2-9 pH range (Figure 57a); addition of 2,2,2,-trifluoroethanol (TFE) 
induced the increase of the ellipticity at 222 nm (Figure 57b). CD parameters are 
summarized in Table 10 and Table 11. 
 
 
 
 
 
 
 
    
   a)      b) 
Figure 57: CD spectra of Fe(III)-MP3 (7 µM, 0.5 cm path length cell, at 25 °C) a) in H2O, pH 2-9; b) at 
various TFE concentration, in phosphate buffer 10mM pH 6.5. 
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Table 10. CD parameters for Fe(III)-MP3 in H20 pH 2-9 
pH [θ]min ·10 -3 (λmin) [θ]222 ·10 -3 [θ]ratio λ0 [θ]190 ·103 
1.9 -14.5   (207.8) -13.4 0.93 200.9 - 
4.1 -14.7   (208.0) -13.4 0.91 200.9 30.5 
6.3 -14.5   (207.6) -12.6 0.87 200.3 26.7 
6.9 -14.9   (207.6) -12.8 0.86 200.3 27.5 
9.2 -14.6   (207.8) -12.7 0.87 200.1 27.0 
 
Table 11. CD parameters for Fe(III)-MP3 in phosphate buffer 10mM pH 6.5 at different %TFE (v/v) 
%TFE(v/v) [θ]min ·10 -3 (λmin) [θ]222 ·10 -3 [θ]ratio λ0 [θ]190 ·103 
0 -14.3   (207.6) -12.4 0.87 200.50 27.1 
10 -19.7   (207.8) -17.6 0.89 200.90 39.8 
20 -21.7   (208.0) -19.4 0.89 200.90 47.1 
30 -23.6   (207.8) -20.6 0.87 200.70 47.8 
40 -24.3   (207.8) -20.9 0.86 200.50 48.1 
50 -24.5  (207.8) -21.0 0.86 200.50 48.5 
70 -25.4  (207.8) -21.7 0.85 200.50 48.7 
 
MP3 is thermodynamically stable in water and at room temperature. Gdn·HCl and 
Urea were used for chemical denaturation studies. CD spectroscopic studies have shown 
that the peptide exists in equilibrium between a folded and an unfolded state. As 
expected, its secondary structure is lost in a single transition when chemical denaturation 
(Gdn·HCl/Urea) is induced. Further, the Gdn·HCl/Urea induced unfolding of MP3 was 
found to be reversible; a full recovery of the ellipticity of the native state was observed 
upon suitable dilution of completely unfolded samples. The free energy of unfolding of 
the MP3 protein was determined by globally fitting the baseline and thermodynamic 
parameters to an equilibrium between folded and unfolded states (Table 12 and Figure 
58). Thus, the apparent free energy of unfolding extrapolated to zero denaturant 
concentration ∆GuH2O of Fe(III)-MP3 was calculated to be 4.5 ± 0.5 kcal·mol-1 (19.0 
kJ·mol-1) at pH 6.5. 
Table 12. Thermodynamic parameters derived from the fit of the guanidine hydrochloride and urea 
induced unfolding curves for Fe(III)-MP3 
Denaturant ∆GuH2O (kcal·mol-1)a [denaturant]1/2 (M) m (kcal·mol-1 M-1) 
Gdn·HCl   4.9 ± 0.3 2.25 1.8 ± 0.1 
Urea   4.2 ± 0.7 5.19 0.7 ± 0.1 
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          a)      b) 
Figure 58: denaturation curves of Fe(III)-MP3 using a) guanidine hydrochloride (Gdn·HCl) b) Urea. 
θ222 was monitored as a function of the concentration of added denaturant in 10 mM phosphate buffer pH 
6.5. 
 
3.1.5.b UV-vis studies 
In order to determine the coordination properties of the molecule, a UV-vis pH 
titration of Fe(III)-MP3 was performed in the pH range 2.0-10.0 in aqueous solutions 
(Figure 59a). There are three well-resolved spectroscopic transitions in the Soret region 
attending the pH change (Figure 59b), with a first midpoint at pH 3.05, a second one at 
pH 5.24 and the last at pH 7.57. We can suggest that at least four species are involved in 
the pH-dependent equilibria. 
 
 
 
 
 
 
 
 
 
 
 
 
 
      a)           b) 
Figure 59: UV-vis pH titration of Fe(III)-MP3 in water a) pH dependence of the near-UV and visible-
region (inset) spectra of Fe(III)-MP3 (3.5 µM, 10 mm path length cell) in water at 25 °C; b) Plot of the 
Soret absorbance at 390nm against pH, showing the visible spectra at various pHs. The theoretical curve 
was fitted to the data over the full pH range and is consistent with three overlapping pKas. 
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Figure 59 shows that at least three protonable groups are involved in the pH 
dependent UV-vis transitions of Fe(III)-MP3. Scheme 4 shows the proposed equilibria 
and the species involved in (distribution as a function of pH at 25 °C in H2O): 
AH33+ →
1
aK
 AH22+ + H+ →
2
aK
 AH11+ + H+ →
3
aK
 A0          Scheme 4 
 
 
 
 
 
 
 
 
 
 
Since the Fe(III)-imidazole complexes are exchange-labile, the observed pH value 
accounts for the competition equilibrium between the coordination of the His axial ligand 
to the heme iron and the protonation of the His in the uncoordinated form. Thus, the 
inflection point value represents the apparent pKa for the protonation of the axially 
coordinated histidines (pKapp), as defined by Kennedy et al. [178]. This means that at any 
given pH there is some population of His side chains not coordinated to Fe(III) and 
available for protonation. 
The UV-vis spectra at various pH of Fe(III)-MP3 in H2O containing 40%TFE 
(Figure 60) are quite different from those recorded in aqueous solution. 
 
 
 
 
 
 
 
 
 
 
 
       a)           b) 
Figure 60: UV-vis pH titration of Fe(III)-MP3 in H2O 40%TFE. a) pH dependence of the near-UV and 
visible-region (inset) spectra of Fe(III)-MP3 (9.6 µM, 10 mm path length cell) in water at 25 °C; b) Plot of 
the Soret absorbance at 390nm against pH, showing the visible spectra at various pHs. The theoretical 
curve was fitted to the data over the full pH range and is consistent with three overlapping pKas. 
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In particular, even though three transitions are clearly observed in the spectra, by 
following the changes in the intensity and position of the Soret band, the bands in the 
visible region show different features. To gain structural insights of the species involved 
in the heme coordination, further characterization by Resonance Raman spectroscopy and 
EPR will be fundamental. 
 
3.1.6 Catalytic activity of MP3 
The peroxidase-like activity of Fe(III)-MP3 was assessed by the use of H2O2 and 
ABTS. The kinetic parameters were first optimized for the oxidation of ABTS: the 
highest peroxidase activity was observed at pH 6.5, 40% TFE (v/v) (Figure 61).  
      
 
 
 
 
 
 
 
       a)         b) 
Figure 61: kcat values for the oxidation of ABTS as a function a) of pH and b) of TFE content. Reaction 
conditions were Fe(III)-MP3 (3.0·10-7 M) 3.0 mM H2O2, 0.1 mM ABTS. Experiments were conducted in 
100 mM phosphate buffer pH 4 -7.6 in a), and in 100 mM phosphate buffer pH 6.5 TFE 0-50% (v/v) in b). 
 
In these experimental conditions the His/H2O axial coordination is predominant and the 
peptide chains reach the maximal helical content, thus suggesting the structural basis for 
Fe(III)-MP3 activity.  
Figure 62 reports the initial rates versus substrate concentrations for the H2O2 
catalyzed oxidation of ABTS, and viceversa. Data fitting, according to two substrate 
reaction Michaelis-Menten kinetics, gave values of   3.4 ± 0.3·10-2 mM, 172 ± 1 mM and 
535 ± 42 s-1, respectively, for KmABTS , KmH2O2 and kcat. 
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      a)      b) 
Figure 62: peroxidase-like activity of Fe(III)-MP3 a) Initial rate of ABTS oxidation as a function of 
substrate concentration. Reaction conditions were Fe(III)-MP3 (1.0·10-7 M) in 100 mM phosphate buffer 
pH 6.5 40% TFE (v/v), 10.0 mM H2O2; b) Initial rate of H2O2 oxidation as a function of substrate 
concentration. Reaction conditions were Fe(III)-MP3 (1.0·10-7 M) in 100 mM phosphate buffer pH 6.5 40% 
TFE (v/v), 0.1 mM ABTS. The data were fitted according to two-substrate Michaelis-Menten kinetic. 
 
The kinetic parameters for H2O2 catalyzed oxidation of Fe(III)-MP3 were compared 
with those of native and mutated peroxidases and some peptide-based peroxidase models, 
such as microperoxidases [179-184] (Table 13). 
 
Table 13. Steady state kinetic parameters for ABTS oxidation by H2O2 catalyzed by Fe(III)-MP3 
pH Km H2O2 Km ABTS kcat kcat/Km H2O2 kcat/KmABTS Enzyme 
 (mM) (s-1) (mM-1·s-1) 
Fe(III)-MP3 6.5 172.5 0.34 535 3.1 1573 
MP8 a 7.0   2.6·10-3 1.73  
MP11a 7.0   13·10-3 6.87  
HRP b, f 4.6  0.8 4100  5125 
HRP c, f 7.0 11.5·10-3 5.1 52.5 4565 10.29 
∗HRP c, g 7.0 13.6·10-3 3.8 57.3 4213 15.08 
R38L ∗HRP c 7.0 8.2 10.8 28.8 3.51 2.67 
R38A hHRP b, h 4.6  0.40 660  1650 
H42A hHRP d 4.6  6·10-3 0.41  68 
Fe(III)ToCPP-13G10 e, i 4.6 16  9.33 0.58  
Fe(III)ToCPP-14H7 e, i 5.0 9  1.05 0.12  
Fe(III)ToCPP2 e, i 5.0 42  0.85 0.02  
a For MP8 and MP11 kcat/Km correspond to the apparent second order rate constant for ABTS formation  
data from reference [182-183], using the rate law d[ABTS+•]/dt= k2 [Enzyme] [H2O2]; b data from ref. 
[179]; c data from ref. [180]; d data from ref. [181]; e data from  ref. [184]; f  HRP horseradish peroxidase 
isoenzyme C (glycosylated form); g ∗HRP non-glycosylated recombinant HRP; h hHRP polyhistidine-
tagged recombinant HRP; i ToCPP: meso-α,α,α,β-tetrakis-orthocarboxyphenyl-porphyrin. 
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3.2 Discussion 
We performed a detailed analysis of the known X-ray structure of heme-binding 
proteins before designing MP1. We used BFR, HRP and cytP450 as template structures: 
these natural proteins show a complex structural organization, in term of secondary and 
tertiary structure. Then we attempted to reproduce the active-site complexity in a de novo 
designed model, also using our experience in the class of DFs and Mimochromes. 
Because of its simplicity relative to other structural motifs, we adopted the four-helix 
bundle motif. Indeed, many of the experiments testing our knowledge of the rules that 
govern protein folding and structure formation have been performed on four-helix 
bundles. The four-helix bundle is compact, possesses a high degree of symmetry and is 
thermodynamically stable: these features make this scaffold convenient to accommodate 
a heme group, and to study how protein matrix tunes the metal site activity.  
In the challenge of MPs design, we were guided by the structural and thermodynamic 
principles that govern protein folding. Indeed, peptides tend to adopt unstructured 
(random-coil) conformations in aqueous solution, even if the corresponding sequence in a 
protein is helical [185]. The main factor discouraging a random-coil peptide from 
becoming helical is the entropically unfavorable decrease in conformational freedom of 
the peptide backbone and of many amino acid side chains (particularly aromatic amino 
acids and residues with β branches [186-187]). In proteins, this is compensated for by (i) 
long-range interactions between amino acid side chains in the helix and those in other 
units of secondary structure (salt bridges, hydrogen bonds, dispersion forces, etc.) and (ii) 
the entropically favorable shedding of high-energy water molecules solvating apolar 
moieties, better known as the hydrophobic effect [188-190]. We tried to stabilize the α-
helices by a sufficient number of ionic interactions between appropriately spaced amino 
acid side chains, and we introduced hydrophobic and aromatic residues engaged in edge-
to-face (T-stacking) interactions with the porphyrin to stabilize the overall dimer folding.  
In addition, the presence of many hydrophobic embedding residues may have an 
important effect in protecting the deuteroporphyrin ring from degradation during catalytic 
cycles. This protective effect is in fact achieved by the polypeptide matrix in heme-
proteins. 
The great challenge was to create a structure that is unique and not geometrically 
fluctuating. This requires that a single topology of the two peptide chains be stabilized. 
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MP models consist of two parts that associate around the heme, to give a folded 
covalently assembled dimer: the covalent bond between the porphyrin and peptide 
moieties should further stabilize the structure and presumably avoid diasteromer 
formation [50], which occurs when the axial ligand dissociates and trades places [71]. 
This problem was encountered in the study of Mimochromes [45-48]. In MPs design we 
inserted interactions between the two peptide chains with the aim of stabilizing only one 
of the two possible diastereomeric forms, or limiting the exchange between multiple 
species.  
The tertiary structure can be described as a sandwich helix-loop-helix/heme/helix-loop-
helix: the two peptide chains embrace the metalloporphyrin and the helix-loop-helix 
segments are antiparallel to each other. 
The general versatile and novel strategy for the syinthesis of helix-heme-helix 
sandwiches in high yields described in the present work will permit a rapid preparation of 
a large variety of analogues with either symmetric or unsymmetric peptide chains.  
The TG-Sieber resin appeared to be suitable for the preparation of partially protected 
peptide amide fragments. Cleavage from this support was effected by treatment with 1% 
TFA in DCM, conditions that leave most standard side chain protecting groups intact and 
the C-terminal carboxylic acid group amidated. 
Another fundamental point was the choice of the protecting group on N-ε function of the 
Lys10, since its removal conditions had to be different than for the other side chain 
protecting groups. The Mmt protecting group was chosen because it can be removed in 
very mild acidic media, by repeated treatments with a solution containing 10% acetic 
acid and 20% trifluoroethanol (TFE) (v/v) in DCM, without affecting the other protecting 
groups [191]. 
In the synthetic procedure, one of the two peptides is coupled to the DEUIX in solution. 
Care was taken to minimize the formation of bis-substituted product by adding dropwise 
the solution containing the peptide to a large excess of DEUIX: the mono-substituted 
ChainK-DEUIX adduct was thus obtained as the major component. 
The stability of the deuteroporphyrin ring in all the synthetic steps avoids the formation 
of by-products. Since the metallation reaction is performed on the assembled peptide-
porphyrin moiety, the incorporation of different metal ions in the porphyrin ring is 
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possible without re-synthesizing the entire molecule, thus opening opportunities for easy 
and fast screening of a wide variety of metal complexes. 
MPs are miniaturized heme-proteins, so they stand at the cross-road between natural 
systems and short peptides: their long sequence should include all the functional elements 
necessary to reproduce the catalytic activity of proteins. The synthesis of MPs was quite 
difficult, and after each trial we passed through redesign to obtain a final product in high 
yields and purity. The synthetic procedure was progressively improved, and the last 
analogue MP3 resulted in a good match between theory (design principles and amino 
acid choice) and practice (sequence-dependent synthesis). 
The iron(III) derivative of MP3 was easily synthesized. UV/vis spectra, coupled with 
CD measurements, in TFE/water buffered solutions, were acquired to confirm the 
designed secondary structure of the model, and the iron (III) coordination. 
Circular dichroism measurements were recorded in the far-UV region, at different pH 
and in presence of the helix-inducing solvent TFE (Figure 57). Table 10 and Table 11 
report the typical CD parameters. The double minima at 222 and 208 nm as well as the 
maximum at about 190 nm indicate the peptides to be predominantly in a helical 
conformation [192]. The ellipticity at 222 nm is the most commonly used parameter to 
describe helix formation. Theoretical calculations have indeed suggested that this value is 
very sensitive to both the length of the helix and to the local conformation of each residue 
[193-197]. Although the [θ]222 value can be correctly applied to calculate the helix 
percentage in proteins, it fails in estimating the helix contents in small peptides. 
Vuillemier and Mutter [198] reported that in small peptides three spectral parameters are 
significant in revealing helix propensity: (i) the [θ]ratio of the minimum at 222 nm to the 
minimum at shorter wavelengths, (ii) the position of this last minimum, (iii) the crossover 
wavelength λ0. In particular, an increase of the [θ]ratio to a value around unity, together 
with a shift of the shorter wavelength minimum toward 207 nm and a shift of the λ0 value 
to longer wavelengths are indicative parameters of high helix propensity. 
Fe(III)-MP3 presents a 88% helix content: this value was estimated by K2D2, a method 
for prediction of protein secondary structure from CD spectra [199]. This value is in good 
agreement with the design hypothesis, since only three residues per helix are involved in 
the loop region. 
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The spectra of the Fe(III)-MP3 at different percentage of TFE present similar features: a 
maximum at about 192 nm, together with a double minimum at 222 and 207 nm (Figure 
57b). As the concentration of TFE increases, the minimum absorption peak (pi→ pi* 
transition) does not show particular shifts, while the ellipticity at 222 nm (n→ pi* 
transition) decreases. Moreover, the crossover λ0 doesn’t significantly shifts to longer 
wavelengths, and the [θ]ratio is constant. These data could suggest that the peptide adopts 
a helix conformation even at low TFE content, and that this solvent does not induce 
conformational transitions. Furthermore, CD experiments at different pHs have supported 
this hypothesis (Figure 57a): all the spectra show the same behavior, suggesting that the 
helix is so well-folded that His coordination (see UV-vis experiments) doesn’t induce 
structural distortion. Further experiments will be necessary to determine the protein 
folding around the heme.  
Gdn·HCl and Urea (Figure 57) were used as chemical denaturants: they offer several 
advantages over other ways of unfolding a protein such as acid, heat, or detergents. First, 
the product is better defined because the degree of unfolding is maximized. Proteins in 8 
M urea or 6 M Gdn·HCI approach a randomly coiled conformation. Second, unfolding is 
more likely to approach a two-state mechanism. And, third, denaturation is more likely to 
be completely reversible. These features are especially important in attempting to 
estimate the conformational stability of a protein. 
The experimental points of the denaturation process both in the presence of Gdn·HCl and 
Urea could well be fitted (R=0.99993) with a simple two state mechanism, and the linear 
extrapolation method (LEM) [200] was used to estimate the effect of the denaturant-
water system on the helix stability. We extrapolated the free energy of unfolding in the 
absence of denaturant (∆GuH2O) to estimate the intrinsic protein stability. Indeed, protein 
denaturation with guanidine hydrochloride or urea provides different estimates of 
stability depending on the contributions of electrostatic interactions [201]. The ionic 
nature of Gdn·HCl masks electrostatic interactions in proteins, a phenomenon that is 
absent when the uncharged urea is used: at low concentrations, Gdn+ and Cl- ions are 
presumed to mask the positively and negatively charged amino acid side chains, thereby 
reducing or even totally eliminating any stabilizing electrostatic interactions. The initial 
decrease in stability observed in the Gdn·HCl denaturation (i.e. a steeper slope of the 
pretransition baseline compared to the urea denaturation curve) may be explained in 
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terms of the masking of electrostatic interaction at low Gdn·HCl concentrations. At high 
concentrations, Gdn·HCl becomes a denaturant, regardless of the types of electrostatic 
interactions present in the protein. The binding of the Gdn+ ions to the proteins is 
presumed to predominate and to push the equilibrium toward the unfolded state [202-
203]. Taken together, these results suggest that the estimates of protein stability from 
Gdn·HCl denaturation studies would likely be a relative measure of the contributions of 
hydrophobic interactions. On the other hand, the denaturing action of urea was presumed 
to be mainly based on its ability to bind to the protein. Because the urea molecule is 
uncharged, it is not expected to have any significant effect on the intermolecular and 
intramolecular electrostatic interactions in the protein. Thus, the free energy of unfolding 
from urea denaturations indicates the net stability of the protein, that is, the sum of the 
stabilizing effect of hydrophobic interactions and the stabilizing effect of electrostatic 
attractions.  
A possible alternative interpretation of the 10 fold difference in the initial and final slop 
of the denaturation process with Gdn·HCl is a more complex mechanism with 
intermediates. To confirm this alternative hypothesis, further denaturation studies will be 
necessary: from temperature denaturation studies we expect to obtain results consistent 
with the urea denaturation data and support the role of hydrophobic interactions in 
stabilizing the “sandwich” structure; using different ionic strength or hydrostatic 
pressure, we could characterize subunit association in MP3; fluorescence emission 
experiments could also be conducted, and the exposure of the single tryptophan residue 
(Trp13) to the aqueous medium could give important information about the mechanism of 
unfolding. 
We used UV-vis spectroscopy to determine the coordination geometry and the spin 
states of Fe(III)-MP3; the UV-vis pH titration in water solution is summarized in Figure 
58.  
At pH 2 the spectrum of Fe(III)-MP3 is characterized by a Soret band at 390 nm, which 
is typical of bis-H2O high-spin (S=5/2) ferric complex. The visible region bands at ~495 
nm (Qv: a1u,a2u (pi) → eg* (pi*)), vibronic component of the Q-B coupled states), ~530nm 
(Qo: a1u,a2u (pi) →eg* (pi*)), ~620 nm (b2u (pi) →eg (dpi)) also indicate that the Fe(III) ion 
in MP3 is in a predominantly S = 5/2 state. The assignments in parentheses are for a 
heme group with D4h symmetry, in agreement with the current convention [204]. 
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At pH 4.3 and 6.5 the spectrum of Fe(III)-MP3 is characteristic of six-coordinate species 
with H2O trans to His, and remains predominantly in the S = 5/2 state. The visible region 
bands at ~522 nm, ~560nm, ~621 nm also indicate that the Fe(III) ion in MP3 is in 
agreement with S = 5/2 spin state. 
At pH above 8 the CT band (b2u (pi) →eg (dpi)), observed below pH 7.0 at ~620 nm, 
disappears; the shift to higher energy of the dpi orbitals of the sextet species is indicative 
of a change in the axial ligands of the metal ion. The electronic spectrum of Fe(III)-MP3 
at pH 9.0 suggests that an hydroxo complex (His-Fe3+-OH-) may exist in the low-spin 
state S = 1/2. 
pKa1 = 3.05 corresponds to the midpoint of bis-H2O to H2O/His coordination equilibrium 
(Scheme 4). This pKa1 value for proximal His coordination is consistent with several 
studies on cytochromes c, and on model heme peptides; pKa2 = 5.24 may correspond to a 
transition that involves de-protonation of an Asp which may form an hydrogen bond with 
the coordinating His, increasing its imidazolate character; pKa3 = 7.57 may correspond to 
the midpoint of H2O/His to OH-/His coordination equilibrium 
Preliminary, pH dependent catalysis of Fe(III)-MP3 in the presence of ABTS and 
H2O2 was studied. The kcat pH dependent profile for the ABTS+• formation is 
characterized by a bell-shape curve [205], with maximum activity at pH 6.5 (Figure 61): 
this profile indicates that at least two ionizable groups are involved in the catalytic 
activity. Their dissociations constants are considered in the fitting equation [205] and the 
values calculated are pKa1=5.10 and pKa2= 7.83, respectively. This result indicated that 
the activity of Fe(III)-MP3 is modulated by the deprotonation of an ionisable group 
having an apparent pKa of 5.10. Potential residue involved in the modulation of this effect 
is the Asp residue in the proximal side, in agreement with the second optical transition 
observed in the UV-vis pH titration (Figure 59).  
The decrease in the kcat value by changing the pH form 6.5 to 8 can be attributed to an 
increase in the molar fraction of the Fe(III)-MP3 complex in the His-iron hydroxide 
coordinated form (Figure 59 and Scheme 4). In fact, the apparent pKa2 calculated by 
fitting the activity vs pH curve well agrees with the midpoint at pH 7.57 of the second 
optical transition observed in the UV-vis pH titration (Figure 59). This pKa has been 
attributed to a ligand exchange of water with hydroxide ion. This ligand exchange 
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occurring at the distal site above pH 6.5 causes the complex to be less able to coordinate, 
and consequently to activate, the peroxide. 
In the oxidation of ABTS none of the synthetic models or mutated proteins developed so 
far has kcat values as high as HRP in the experimental conditions for its maximal activity 
(kcat = 4100 s-1, pH 4.6). However, at neutral pH, Fe(III)-MP3 approaches the HRP 
catalytic performance. Its Kcat is only 7.7-fold lower than that of HRP, in the 
experimental conditions for maximal activity for each enzyme, while Fe(III)-MP3 Kcat is 
10-fold higher than that of HRP at neutral pH.  
Fe(III)-MP3 shows Km and Kcat values comparable to those of R38A hHRP mutant, 
suggesting that distal Arg doesn’t support catalysis. The Arg14 rotamer has many freedom 
degrees, and one of them point toward the metal center (Figure 63); alternatively, the 
electrostatic repulsion with Arg26, which could not be necessary involved in the inter-
chain ion pairing with Asp41, could push out the Arg14, which becomes solvent exposed. 
 
 
 
 
 
 
 
 
 
 
 
Figure 63: 3D molecular model of active site in Fe-MP3. Surface representation of the two peptide 
chains, and catalytically active Arg14 and inter-chain ion pair Arg26/Asp41 residues are depicted as sticks.  
 
Further solution or solid state characterizations will be necessary to elucidate the 
residues arrangement in the active site, while stopped-flow kinetic experiments will 
define the catalytic mechanism and the structural intermediates involved in. Furthermore, 
kinetic experiments using different substrates will give insights into selectivity of our 
model.  All characterization data will be considered to redesign MP3, to obtain a stable 
and soluble de novo protein scaffold, to be used as catalyst with high selectivity and 
efficiency. 
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3.3 Experimental section 
Reagents were obtained from commercial suppliers and used as received. All amino 
acids, the Sieber resin, O-7-Azabenzotriazol-1-yl-N,N,N’,N’’-tetramethyluronium 
hexafluorophosphate (HATU), hydroxybenzotriazole (HOBt) and Benzotriazol-1-yl-oxy-
tripyrrolidinophosphonium hexafluorophosphate (PyBOP) were purchased from Nova 
Biochem; piperidine, and scavengers were from Fluka. DIEA and TFA were from 
Applied Biosystems. All solvents used in the peptide synthesis and purification were 
anhydrous and HPLC grade respectively, and were supplied by Romil. Deuteroporphyrin 
IX was from Porphyrin Products. Iron(II) acetate was from Aldrich. Solvent mixtures are 
indicated in the respective sections. Bio-Beads S-X1 (200-400 mesh) was from Bio-Rad. 
Precoated silica G-60 plates, F254, were used for thin-layer chromatography (TLC). The 
substrates ABTS used in the catalytic assays was purchased from Sigma-Aldrich and was 
used without further purification. 3 H2O2 (30%, v/v) and all the standard chemicals were 
obtained from Fluka. 
 
3.3.1 Design  
Molecular design was performed on a Silicon Graphic Octane 2 workstation. The 
program package InsightII/Discover with Extensible Systematic Force Field (ESFF) 
[206], was used for energy minimization and restrained molecular dynamic (RMD) 
simulation. The X-ray structure of HRP (PDB: 1HCH), BFR (PDB: 1BFR), and the 
solution structure of Co(III)-Mimochrome IV (PDB: 1PYZ) and DF3 (PDB: 2KIK) were 
used as template for modeling the MPs molecule. The structures were generated with 
Visual Molecular Dynamics (VMD;  http://www.ks.uiuc.edu/Research/vmd/). 
 
3.3.2 Peptide synthesis and purification 
MPs molecules were chemically synthesized by automated solid-phase synthesis 
using an ABI 433A peptide synthesizer (Applied Biosystems, Foster City, CA, USA). 
The N- termini was acetylated. The instrumental software Fmoc protocols were modified 
to provide an improved synthetic outcome. HOBt activation was used instead of the 
instrumental HATU activation, and DIEA/DMF solution used as base. N-α Fmoc 
deprotection was accomplished with a solution of 20% piperidine / NMP (volume 
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percentage); single coupling was conducted for each amino acid, and double coupling 
was conducted for the last 14 residues. Capping reaction was performed after each 
coupling step, using Ac2O/HOBt/DIEA solution in NMP. The synthesis was carried out 
on a 0.1-mmol scale using a TG-Sieber resin from Nova Biochem (substitution level 0.2 
mmol · g-1). Protected amino acids used for all MPs molecules were: 
Fmoc-Arg(Pbf)-OH, Fmoc-Asp(OtBu)-OH, Fmoc-Asn(Trt)-OH, Fmoc-His(Trt)-OH, 
Fmoc-Glu(OtBu)-OH, Fmoc-Gln(Trt)-OH, Fmoc-Gly-OH, Fmoc-Ile-OH, Fmoc-Leu-
OH, Fmoc-Lys(Boc)-OH, Fmoc-Lys(Mmt)-OH, Fmoc-Phe-OH, Fmoc-Pro-OH, Fmoc-
Ser(tBu)-OH, Fmoc-Thr(tBu)-OH, Fmoc-Trp(Boc)-OH, Fmoc-Val-OH, Fmoc-
homoCys(Trt)-OH. 
Analysis of reaction mixtures and products of protected peptides was performed by 
TLC on silica, while their purification was accomplished by gel-filtration using a 
BioBeads S-X1 resin (200-400 mesh, m.w. operating range 600-14000) and DMF as 
eluent. Peptide identity was checked via LC-MS after deprotection of small aliquots of 
reaction mixture, using TFA/EDT/Anisole/Tioanisole 90/3/2/5 as cleavage solution. The 
reaction was conducted at 0 °C for 1h and at room temperature for the second hour; the 
final mixture was concentrated on a rotary evaporator to a volume of approximately 1-2 
mL. Extraction of the scavengers and precipitation of the crude product was achieved by 
addition of cold diethylether. The crude material was then dried in vacuo and the fully 
deprotected peptides were analyzed to homogeneity by analytical reverse-phase high-
performance liquid chromatography (RP-HPLC), performed with a Shimadzu LC-
10ADvp equipped with a SPDM10Avp diode-array detector. A Vydac C8 column (4.6 
mm · 150 mm; 5 µm), eluted with an H2O/ 0.1% trifluoroacetic acid (TFA) (solvent A) 
and CH3CN/ 0.1% TFA (solvent B) linear gradient, from 10 to 80% (solvent B) over 35 
min, at 1 mL·min-1 flowrate, was used in all analyses. Purification was accomplished by 
preparative RP-HPLC (22 mm · 250 mm; 10 µm) Vydac C8 column, at a flow rate of 22 
mL·min-1, with a gradient of acetonitrile in 0.1% aqueous TFA, from 10 to 80% over 58.1 
min. Pure MP3 was obtained in 10% yield from the crude product and its purity was 
ascertained by analytical RP-HPLC and matrix-assisted laser desorption ionization time 
of flight mass spectrometry. 
Selective removal of Mmt group of lysine was accomplished using Acetic acid/TFE 
6/4 solution, and completeness of the reaction was checked by the Kaiser test [207]. 
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Fully protected peptide amide was generated from the resin by applying a 1% TFA-
(adding 1% EDT for chain J)/ DCM (volume percentage) solution under nitrogen 
pressure, and collecting it into an ice-cooled flask containing 10% pyridine/ methanol 
(volume percentage). Finally, the resin was washed with DCM and methanol. The 
filtrates that contained product (checked by TLC in chloroform/methanol 90/10) were 
combined and evaporated under reduced pressure up to 5% of the volume. N-hexane for 
ChainJ and water for ChainK were added to the residue and the mixture was cooled on 
ice to aid precipitation of the protected peptide. The product was filtered, washed several 
times with fresh n-hexane or water, and dried under vacuum to give the crude C-terminal 
peptide amide. After gel-filtration, ChainK was coupled dropwise to DEUIX (10-fold 
excess) using HOBt/PyBOP as activating agents and DIEA as base. The monopeptide 
adduct, purified by gel-filtration, was coupled to the other peptide (ChainK+DEU:Chain J 
1:1.5) and the reaction was allowed to proceed at room temperature for a total of 24h. 
The pH was checked during the reaction time. The reaction progress was followed by 
TLC and by analytical HPLC, after deprotection of a small amount of reaction mixture. 
 
3.3.3 UV–vis analysis 
UV-visible spectra were recorded on a Cary Varian 50 Spectrophotometer. Quartz 
cuvettes with a pathlength of 1.0 cm or 0.5 cm were used for most measurement. 
Wavelength scans were performed at 25 °C (unless otherwise specified) from 200 nm to 
800 nm, with a 300 nm·min-1 scan speed.  
 
3.3.3.a Preparation of Fe(III)-MP3 complex 
Iron ion was inserted into MP3 according to literature procedures [176]. Iron (II) 
acetate (10-fold excess) was added to a solution of crude MP3 in Acetic Acid/TFE  6/4 
solution, and the reaction mixture was kept at 40 °C for 1 h and at room temperature for 
the second hour, refluxing under nitrogen. The reaction was monitored by analytical 
HPLC. The solvent was then removed under vacuum, and the product was purified to 
homogeneity by preparative RP-HPLC and LC-MS confirmed the expected molecular 
weight (Fe(III)-MP3 = 10,168.5 amu).  
Stock solutions of Fe(III)-MP3 (2.0−4.0 ·10-4 M) in water were prepared and stored at 
4 °C when not in use. Fe(III)-MP3 stock solutions were appropriately diluted with water 
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0.1% (v/v) TFA and used for determining the extinction coefficients at the Soret band 
maximum wavelength. Their concentrations were determined by flame atomic absorption 
spectrometry, on the basis of their metal content. Typically, ~5 · 10-6 M solutions of 
metal-reconstituted MP3 (corresponding to ca. 0.3 mg·L-1 of metal) in ultra pure metal-
free water with 0.1% (v/v) TFA (pH 1.9) were directly aspired into an air-acetylene flame 
with no prior treatment. Concentrations were obtained by comparison with calibration 
curves. 0.1% (v/v) TFA (pH 1.9) water solutions used to dissolve Fe(III)-MP3 were also 
checked for metal content, and found to be free of metal within the experimental error. 
The final ε387 = 85,683 cm-1·M-1 is referred to the Soret band and in water with 0.1% 
(v/v) TFA (pH 1.9). 
 
3.3.3.b pH titrations 
Two pH titration experiments of Fe(III)-MP3 were carried out in water and in 
TFE/water 40/60 (v/v) at room temperature. Stock solution was diluted with water to 
final concentration of 3.5·10-6 M and 7.5·10-6 M for the two experiments in presence and 
in absence of TFE, respectively. NaOH 0.1M was used for the basic titration, while TFA 
0.1%, 1% 10% (v/v) water solutions or pure TFA were used in the acid titration; dilution 
was less than 1 % and considered in the final data. The pKa’s were determined by 
monitoring the changes in absorbance at 390 nm (the Soret maximum for the Fe(III)-MP3 
at pH 1.9) as a function of proton concentration. The data were analyzed assuming 
equilibria reported in the equation: 
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and each of them can be expressed in dependence of [A0]. The total absorbance and the 
total concentration can be expressed as sum of the all species: 
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Eq.3 is multiplied and divided by Eq.4, obtaining: 
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which can be written as: 
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where Absi are the absorbance of the different protonated species. Eq.6 was used to fit 
the observed Abs390nm as function of [H+]. 
 
3.3.3.c Catalytic assays 
The catalytic experiments were followed using a Varian Cary 50 spectrophotometer, 
by measuring the appearance of the products in the reaction medium. The substrate used 
in the catalytic assays was ABTS [208]: a ~1.0 mM stock solution was prepared in 
phosphate buffer 100mM pH 6.5, 40% TFE (v/v), and its concentration quantified 
spectrophotometrically (λmax (ε) = 340 nm (3.66 · 104 M-1·cm-1)) ; H2O2 stock solutions 
were prepared diluting H2O2 (30%, v/v) in water and quantified spectrophotometrically 
(λmax (ε) = 240 nm (39.4 M-1·cm-1)). The change in absorbance of the ABTS+• cation 
radical was followed at 660 nm (λmax (ε)=660 nm (1.40 ·104 M-1·cm-1)). 
Kinetic parameters of Fe(III)-MP3 were determined by varying H2O2 concentration 
using fixed concentrations of reducing substrate, and vice versa. In the experiments 
performed at variable H2O2 concentration (in the range 5-250 mM) the ABTS 
concentration was kept constant at 0.1 mM. In the experiments performed at variable 
ABTS concentration (in the range 0.01-2.0 mM) the H2O2 concentration was 10 mM. In 
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all the experiments Fe(III)-MP3 concentration was 1.0 · 10-7 M and reaction volume was 
600 µL.  
The Km and Kcat were determined using a two-substrate Michaelis-Menten kinetic 
model [209]. Data were analyzed using the following equation: 
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K
]A[K
K
K
1
]E[
v
cat
mB
cat
mA
cat
0
++
=  
Where v is the initial rate, [E]0 is the enzyme concentration, [A] is the H2O2 
concentration, [B] is the reducing agent.  
 
3.3.4 Circular dichroism analysis 
CD experiments were performed on a Jasco J-715 circular dichroism 
spectropolarimeter at 25 °C. Temperature control was achieved using a Peltier (± 0.5 °C 
accuracy). For all studies, cell path length was 0.5 cm. Spectra in the 190-260 nm region 
were collected at 0.2 nm intervals with a 10 nm·min-1 scan speed, 1 nm bandwidth and a 
16 s response. Spectra are reported in terms of mean residue ellipticity, calculated by 
dividing the total molar ellipticity by the number of amino acids in the molecule (83). 
The concentration of Fe(III)-MP3 was 6.0-7.5 · 10-6 M in water for the pH titration, and 
in phosphate buffer 10mM pH 6.7 for TFE titration and chemical denaturations. 
 
 3.3.4.a pH and TFE titrations 
Stock solution of Fe(III)-MP3 in water was diluted to the final concentration of  7.0 · 
10-6 M in water for pH titration. The acidic titration was conducted using TFA 1% in 
water (v/v), while NaOH 0.1M was used to reach pH 9. For TFE titration, different 
solutions were prepared diluting the stock solution to the final concentration of 7.0 · 10-6 
M in phosphate buffer 10mM pH 6.7, varying the TFE percentage. 
 
3.3.4.b Chemical denaturations 
For chemical denaturation experiments, stock solutions of Gdn·HCl 8M and Urea 
10M were prepared dissolving the denaturant in phosphate buffer 10mM pH 6.7. Stock 
solution of Fe(III)-MP3 in water was diluted to the final concentration of  7.5 · 10-6 M 
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and 6.0 · 10-6 M in phosphate buffer 10mM pH 6.7, for Gdn·HCl and for Urea 
denaturation respectively. 
A titration was conducted for the chemical denaturation with Gdn·HCl: two solutions 
with the same protein concentration were prepared, the first without denaturant and the 
second in the presence of Gdn·HCl 8M (the final concentration was 7.84 M for dilution 
effect). Titration was accomplished taking a volume from the first solution and re-adding 
the same amount from the second solution: the protein concentration remained 
unchanged while the Gdn·HCl concentration was increased step by step (0–6 M, with 
approximately 0.3 M increments). The sample was allowed to equilibrate for 30 minutes 
and then the spectrum was acquired. For each point the equations was:   
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where [Gdn·HCl]i is the observed denaturant concentration,  [Gdn·HCl]i-1 is the previous 
denaturant concentration, the Fsolution is the original solution prepared without denaturant 
and  Usolution is the second solution at [Gdn·HCl]= 7.84M.  
For the Urea denaturation, different samples were prepared at different denaturant 
concentration (0–9.5 M, with approximately 0.5 M increments) and they were left to 
equilibrate for 12 h before measurement.  
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Chemical denaturation curves were obtained by monitoring the CD signal at 222 nm 
upon denaturant addition, with a 60 s averaging time. Data were normalized as the 
fraction unfolded (fu), calculated as fu = (θobs – θ0)/( θ∞ – θ0), in which θobs, θ0, θ∞  
represent the ellipticity at the actual denaturant concentration, at zero denaturant 
concentration, and of the unfolded protein, respectively. The data curves were fit 
according to the equilibrium: 
F ↔ U 
in which F is the folded protein in equilibrium with the unfolded species. The data were 
analyzed by the linear extrapolation method using the two-state mechanism: 
        (Eq.7) 
where fU and fF are the fraction folded and unfolded respectively. Using the previous 
equations we can express θobs as function of denaturant concentration: 
 
  
 (Eq.8) 
 
The two members of Eq.8 that correspond to fU can be re-arranged as follow: 
 
 
 
        (Eq.9) 
    
Finally, the data were analyzed by the LEM using the following equation: 
         
                   
                  (Eq.10) 
 
 
 
where: 
 
 
where ∆GuH2O is an estimate of the conformational stability of a protein that assumes that 
the linear dependence continues to 0 M denaturant, and m is a measure of the dependence 
of ∆G on denaturant concentration.
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Metalloprotein design using de novo-designed or native protein scaffolds has 
succeeded in providing valuable insights into the fundamental rules that govern protein 
structure and function. Replicating native protein structure and function, although 
challenging, is not the only goal of protein designers; they want to build proteins with 
properties that exceed those found in nature [210]. In recent years, the repertoire of 
functional groups such as amino acids or cofactors available to protein designers has been 
expanded beyond that available in biological systems. The successful synthesis and 
application of novel metal complexes or metalloenzymes can have a great impact on all 
areas of chemistry and biology, whether it is organic, medicinal, materials chemistry, or 
biochemistry and cell biology. An important example of such an impact is the 
development of metal catalysts for reactions such as nitrogen fixation, methane 
hydroxylation, and CO oxidation or insertion. These catalysts are key components for 
multibillion-dollar chemical industries that produce vital raw chemicals, such as 
fertilizers. 
Progress with de novo synthesis of peptides gives the opportunity to construct 
chemically simple systems that incorporate biological redox sites: they give important 
insights about molecular engineering involved in their assembly and the minimal 
requirements to work as their highly complex natural counterparts. Hence, these synthetic 
proteins would play a role analogous to the small three-dimensional models called 
maquettes used by sculptors and architects to appreciate various aspects of full-scale 
products. It is essential that structures avoid the rather nonspecific ensemble of folds 
commonly found in previous synthetic peptides, and to this end it is pertinent that more 
native-like properties have been achieved by incorporating a metal-binding site into a 
good scaffold, such as the four-helix bundle [211-212].  
Four-helix bundle proteins are ubiquitous in nature and serve as convenient scaffolds 
for the construction of simplified functional versions of complex natural enzymes or 
molecular maquettes. These bundles are compact, possess a high degree of secondary 
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structure and are thermodynamically very stable: these features make it a convenient 
scaffold to accommodate an active site, and to study how protein matrix tunes its activity. 
 
 
4.1 Artificial di-iron oxo proteins: DF models  
This thesis reports the functional and chemico-physical properties of DF3, a de novo 
designed di-iron protein model. DF3 is the latest member of the DF family of synthetic 
proteins [9]. They consist of helix–loop–helix hairpins, designed to dimerize and form an 
antiparallel four-helix bundle that encompasses a metal-binding site similar to those of 
non-heme carboxylate-bridged di-iron proteins. Unlike previous DF proteins, DF3 is 
highly soluble in water (up to 3 mM) and forms stable complexes with several metal ions 
(Zn, Co, and Mn), with the desired secondary structure and the expected stoichiometry of 
two ions per protein. UV–vis studies of Co(II) and Fe(III) complexes confirm a metal-
binding environment similar to previous di-Co(II)- and di-Fe(III)-DF proteins, including 
the presence of a µ-oxo-di-Fe(III) unit. Interestingly, UV–vis, EPR, and resonance 
Raman studies suggest the interaction of a tyrosine adjacent to the di-Fe(III) center. The 
design of DF3 was aimed at increasing the accessibility of small molecules to the active 
site of the four-helix bundle. Indeed, binding of azide to the di-Fe(III) site demonstrates a 
more accessible metal site compared with previous DFs: fitting of the binding curve to 
the Hill’s equation allows to quantify a 150% accessibility enhancement, with respect to 
DF2.  
All the spectroscopic and structural features reported herein demonstrate the ability of 
a designed protein to finely tune the active-site structure to accommodate different metal 
ions and exogenous ligands. Further, the complete analysis of the di-iron complex 
supports the ability of di-Fe(III)–DF3 to catalyze oxidation reactions, in particular of 
phenols to quinines.  To confirm the structural basis for DF3 catalytic activity, its NMR 
solution structure was solved using the diamagnetic di-Zn(II) derivative. 
In conclusion, DF3 is a promising candidate for further adjustments in the structure 
aimed at developing functional models of dinuclear metalloproteins housing redox-active 
metal ions. The availability of the DF3 scaffold should now allow explore how changes 
to the first- and second-shell ligands as well as residues lining the substrate binding cleft 
affect the reactivity and catalytic properties of the protein. 
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Current studies on DFs sequence are aimed to better evaluate the loop influence on 
the overall structure stability; the final goal is a minimal model capable of oxidizing the 
C-H bond in methane as well as other alkanes, reproducing the catalytic activity of 
methane monoxigenase. 
 
 
4.2 Artificial heme-proteins: MP models 
This thesis also reports the de novo design procedure of MPs, a new class of heme-
peptide based models, which have been developed to show HRP- or cytP450-like 
activities, using H2O2 as oxidizing agent. De novo design was based on the structural and 
functional properties of natural proteins BFR, HRP and cytP450, as well as of 
miniaturized models DFs and Mimochromes. The structural information available on 
four-helix bundle systems brought us to introduce in these rigid scaffolds novel 
functionalities; the ultimate goal is to obtain metalloprotein analogues, as highly efficient 
and selective catalysts. 
De novo design principles led us to engineer a helix-loop-helix/heme/helix-loop-helix 
system. A trial and error procedure was unavoidable for this new class of models: only 
the last analogue, MP3, was synthesized with high purity, as necessary for spectroscopic 
characterization.  
MP3 was partially characterized as the iron ion species, and we estimated its 
biocatalytic efficiency respect to natural systems. 
Firstly, CD and UV-Vis spectroscopies were used to obtain structural and 
thermodynamic information. They confirmed the peptide chains to be in helical 
conformation and to coordinate the metal ion by the His residue, as designed.  
In addition, peroxidase activity of Fe(III)-MP3 was investigated using 2,2’-azino-
di(3-ethyl-benzothiazoline-6-sulfonic acid) (ABTS) and H2O2.  
In conclusion, all the spectroscopic and functional properties described in this thesis 
indicate that Fe(III)-MP3 is an efficient five-coordinate heme-protein model, which 
houses a peroxidase-like active site. MP3 peptide framework, despite its small structure, 
confers higher efficiency to the porphyrin cofactor, compared to other peroxidase 
mimics. Most of them are based on more or less sophisticated iron porphyrins working in 
organic solvents. These models are able to mimic most of the reactions catalyzed by 
Chapter 4 - Conclusions and perspectives 
 
 
 - 109 - 
heme-proteins, but the lack of specific substrate recognition sites in their structures 
causes the loss of selectivity which is exhibited by heme-proteins. On the contrary, our 
water soluble models could be engineered for selective substrate recognition by the 
peptide moiety in close proximity to the iron porphyrin catalytic site. MP3 is an excellent 
scaffold for further design of heme based biocatalysts.  
In conclusion, our work confirms the correctness of de novo design principles to 
obtain proteins with useful functions and applications. The growing knowledge of these 
principles allows us to shift our attention towards function, as focus of design. Our 
studies lay the basis to the construction of a wide variety of enzymes which mimic, 
recreate and/or extend the catalytic functionalities present in biology, leading to a great 
benefit both medicinally and industrially. 
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guided approach to design peptide mimetics of the N-loop and β1-strand regions of RANTES/CCL5, which 
contain the primary molecular determinants of HIV-1 blockade. Rational modifications were sequentially 
introduced into the N-loop/ β 1-strand sequence leading to the generation of mimetics with potent activity 
against a broad spectrum of CCR5-specific HIV-1 isolates (IC50 range, 104- 640 nM), but lacking activity 
against CXCR4-specific HIV-1 isolates. Functional enhancement was initially achieved with the 
stabilization of the N-loop in the β-extended conformation adopted in full-length RANTES, as confirmed 
by NMR analysis. But the most dramatic increase in antiviral potency resulted from the engraftment of an 
in silico-optimized linker segment designed using de novo structure-prediction algorithms to stabilize the 
C-terminal α-helix and experimentally validated by NMR. Our mimetics exerted CCR5-antagonistic 
effects, demonstrating that the antiviral and proinflammatory functions of RANTES can be uncoupled. 
RANTES peptide mimetics provide new leads for the development of safe and effective HIV-1 entry 
inhibitors. 
